ciprofloxacin has been researched along with rifampin in 548 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 35 (6.39) | 18.7374 |
1990's | 115 (20.99) | 18.2507 |
2000's | 150 (27.37) | 29.6817 |
2010's | 201 (36.68) | 24.3611 |
2020's | 47 (8.58) | 2.80 |
Authors | Studies |
---|---|
Maiese, WM; Singh, MP; Timmermann, BN; Wächter, G; Woldemichael, GM | 1 |
Sriram, D; Thirumurugan, R; Yogeeswari, P | 1 |
Hamann, MT; Kasanah, N; Rao, KV; Schinazi, RF; Tekwani, BL; Wahyuono, S | 1 |
Christiansen, HC; Copp, BR; G Franzblau, S; Lindsay, BS | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Eldridge, GR; Garo, E; Goering, MG; Hough, GW; Hu, JF; O'Neil-Johnson, M | 1 |
Alonso, D; Donia, MS; Franzblau, SG; Garcia-Palomero, E; Hamann, MT; Khan, SI; Martinez, A; Medina, M; Peng, J; Rao, KV; Tekwani, BL; Wahyuono, S; Willett, KL | 1 |
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
Bartels, DJ; Charifson, PS; Grillot, AL; Gross, CH; Grossman, TH; Liao, Y; Mani, N; Mullin, S; Olson, ER; Parsons, JD; Stamos, D | 1 |
Chen, YG; Du, XX; Li, LJ; Shen, P; Wei, ZQ; Yu, YS | 1 |
Alba, L; Chen, Y; Garber, E; Saiman, L; Tabibi, S; Zhou, J | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Heldreth, B; Jang, S; Long, TE; Revell, KD; Turos, E | 1 |
Noskin, GA; Obias, A; Postelnick, MJ; Qi, C; Scheetz, MH; Warren, JR; Zembower, T | 1 |
Brouillette, CG; Brouillette, WJ; DeLucas, LJ; Luan, CH; Mou, L; Velu, SE; Yang, ZW | 1 |
Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
Bastide, L; Gualtieri, M; Leonetti, JP; Villain-Guillot, P | 1 |
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Hamann, MT; Kasanah, N; Shilabin, AG; Wedge, DE | 1 |
Dahl, EL; Rosenthal, PJ | 1 |
Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, M; Ofner-Agostini, M; Simor, AE; Stuart, TL; Watt, C | 1 |
Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
Campbell, BJ; Edwards, SW; Hart, CA; Martin, HM; Rhodes, JM; Roberts, CL; Subramanian, S | 1 |
Collins, MT; Shin, SJ | 1 |
Bitting, C; Gruppo, V; Johnson, CM; Lenaerts, AJ; Marietta, KS; Orme, IM; Woolhiser, L | 1 |
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
Besier, S; Brade, V; Kahl, BC; Kraiczy, P; Wichelhaus, TA; Zander, J | 1 |
Chopra, I; Ingham, E; Miller, K; O'Neill, AJ; Wilcox, MH | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Bonventre, EJ; Doyle, TB; Du, Q; Duncan, L; Lynch, AS; Morris, TW; Robertson, GT; Roche, ED; Yan, D | 1 |
Alba, V; Blasco, MD; Espinal, P; Fernández-Cuenca, F; Marti, S; Pascual, A; Ruiz, M; Sánchez-Céspedes, J; Vila, J | 1 |
Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
Arhin, FF; Bassett, A; Bassett, J; Heine, HS; Ivins, BE; Lehoux, D; Miller, L; Moeck, G; Parr, TR | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
del Pozo, JL; Mandrekar, JN; Patel, R; Rouse, MS; Sampedro, MF; Steckelberg, JM | 1 |
Bauraing, C; Bogaerts, P; Cuzon, G; Deplano, A; Glupczynski, Y; Lissoir, B; Naas, T; Nordmann, P | 1 |
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
Chen, H; Chen, M; Du, N; Liu, Y; Niu, J; Shen, E; Wang, H; Ye, H | 1 |
Langsley, G; Lizundia, R; Ralph, SA; Werling, D | 1 |
Banerjee, D; Dhakla, P; Manjashetty, TH; Senthilkumar, P; Sriram, D; Yogeeswari, P | 1 |
Caugant, DA; Fredlund, H; Hedberg, ST; Nicolas, P; Olcén, P; Unemo, M | 1 |
Chlipala, G; Krunic, A; Mo, S; Orjala, J | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Amirthaganesan, S; Aridoss, G; Jeong, YT; Kim, JT; Kim, MS | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Bavari, S; Bowlin, T; Butler, MM; Gussio, R; Houseweart, C; Lane, D; Moir, DT; Nguyen, T; Opperman, T; Panchal, RG; Peet, NP; Ulrich, RL; Williams, JD | 1 |
Cheung, CM; Firestine, SM; Rybak, MJ; Vooturi, SK | 1 |
Gebreyes, WA; Rajamohan, G; Srinivasan, VB | 1 |
Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R | 1 |
Kumar, RS; Perumal, S; Shetty, KA; Sriram, D; Yogeeswari, P | 1 |
Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choo, YM; Doerksen, RJ; Gertsch, J; Hamann, MT; Jacob, MR; Khan, SI; Kudrimoti, S; Madgula, V; Mayer, AM; Odde, S; Peng, J; Pennaka, HK; Prasanna, S; Rao, KV; Tekwani, BL; Tu, LC; Wang, B | 1 |
Adhikari, AV; Ajay Kumar, R; Eswaran, S | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Ding, Y; Ferreira, D; Franzblau, S; Hamann, MT; Kelly, M; Li, XC; Na, M; Schinazi, RF; Stone, R; Tekwani, BL; Wang, B | 1 |
Adhikari, AV; Chowdhury, IH; Eswaran, S; Pal, NK; Thomas, KD | 1 |
Fuller, CA; McGannon, CM; Weiss, AA | 1 |
Bohnert, JA; Karamian, B; Nikaido, H | 1 |
Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
Abdullah, ST; Ahmed, SK; Azeeza, S; Kamal, A; Khan, IA; Reddy, AM; Sharma, S; Shetti, RV; Swapna, P | 1 |
Chan, JL; Cheung, GY; Joo, HS; Otto, M | 1 |
Basset, P; Blanc, DS; Senn, L; Vogel, V; Zanetti, G | 1 |
Haveliwala, DD; Kamdar, NR; Mistry, PT; Patel, SK | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Balamurugan, K; Perumal, S; Prasanna, P; Sriram, D; Yogeeswari, P | 1 |
Balamurugan, K; Maheswari, SU; Perumal, S; Sriram, D; Yogeeswari, P | 1 |
Briguglio, I; Carta, A; Corona, P; Guglierame, P; Jabes, D; Molicotti, P; Palomba, M; Piras, S; Zanetti, S | 1 |
Chai, Y; Feng, LS; Guan, Y; Guo, HY; Liu, ML; Lv, K; Wang, B; Xiao, CL; Zhang, S; Zhang, YB | 1 |
Chiba, T; Hasegawa, T; Horita, Y; Kremer, L; Kuroishi, R; Lee, Y; Ogawa, K; Onozaki, K; Sato, Y; Takii, T | 1 |
Adhikari, AV; Chowdhury, IH; Pal, NK; Sumesh, E; Thomas, KD | 1 |
Kumar, RS; Libertsen, LA; Perumal, S; Rajesh, SM; Sriram, D; Yogeeswari, P | 1 |
Menéndez, JC; Perumal, S; Ranjith Kumar, R; Sriram, D; Yogeeswari, P | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Gunasekaran, P; Perumal, S; Sriram, D; Yogeeswari, P | 1 |
Chitra, S; Manisankar, P; Muthusubramanian, S; Paul, N; Sriram, D; Yogeeswari, P | 2 |
Adhikari, AV; Bhattacharya, B; Chowdhury, IH; Mahmood, R; Sandeep, T; Sumesh, E; Thomas, KD | 1 |
Adhikari, AV; Chowdhury, IH; Mahmood, R; Pal, NK; Row, G; Sumesh, E; Telkar, S; Thomas, KD | 1 |
Aiello, C; Anzaldi, M; Balbi, A; Castagnola, P; Gangemi, R; Macciò, C; Mazzei, M; Miele, M; Rosano, C; Viale, M | 1 |
Akhaja, TN; Raval, JP | 1 |
Murugavel, M; Muthusubramanian, S; Paul, N; Sriram, D | 1 |
Haridas, KR; Karuvalam, RP; Kumari, NS; Nayak, SK; Rajeesh, P; Rishikesan, R; Row, TN | 1 |
Constant, P; Daffé, M; Massimba Dibama, H; Mourer, M; Regnouf-de-Vains, JB | 1 |
Bucar, F; Gröblacher, B; Kunert, O | 1 |
Chikhalia, KH; Kumari, P; Patel, PK; Patel, RV; Rajani, DP | 1 |
Almansour, AI; Arumugam, N; Sriram, D; Suresh Kumar, R | 1 |
Patel, MP; Patel, RG; Shah, NM | 1 |
Chovatia, PT; Parekh, HH; Pathak, RB | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Kathrotiya, HG; Patel, MP | 1 |
Jardosh, HH; Patel, MP | 1 |
Haridas, KR; Kumari, NS; Rajeesh, P; Ranjith, PK; Rishikesan, R; Row, TN; Susanta, NK | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Khan, IA; Kondapalli Venkata Gowri, CS; Nagesh, HN; Rajput, V; Renuka, J; Sharma, R; Suresh, N | 1 |
Haridas, KR; Kumari, SN; Pakkath, R; Ranjith, PK | 1 |
Balkan, A; Dharmarajan, S; Ozadali, K; Tan, OU; Yogeeswari, P | 1 |
Kalaria, PN; Raval, DK; Satasia, SP | 1 |
Genta-Jouve, G; Greff, S; Massi, L; Perez, T; Thomas, OP; Zubia, M | 1 |
Achar, V; Arora, U; Awasthy, D; Bharath, S; Bheemarao, U; Chinnapattu, M; Coulson, M; de Sousa, SM; Ganguly, S; Gaonkar, S; Ghosh, A; Hameed P, S; Hoffner, S; Humnabadkar, V; Kaur, P; Kumar K N, M; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Menasinakai, S; Mukherjee, K; Nandishaiah, R; Narayan, C; Panduga, V; Patil, V; Puttur, J; Raichurkar, A; Ramya, VK; Reddy, J; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Sharma, U; Shinde, V; Solapure, S; Waterson, D; Werngren, J | 1 |
Karad, SC; Purohit, VB; Raval, DK | 1 |
Basireddy, VS; Dharmarajan, S; Guttala, RS; Jagarlamudi, PS; Mukkara, LD; Pagadala, LR; Perumal, Y; Ravirala, N; Singh, A; Singireddi, S; Thummaluru, VR; Ummanni, R; Upadhyayula, SM | 1 |
Hameed P, S; Kaur, P; Madhavapeddi, P; Menasinakai, S; Nandishaiah, R; Panduga, V; Raichurkar, A; Reddy, J; Sambandamurthy, VK; Sharma, S; Sriram, D | 1 |
Guo, H; Huang, J; Liu, H; Liu, M; Lu, Y; Wang, B; Wang, J; Wang, M | 1 |
Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
Cho, S; Franzblau, SG; Miller, MJ; Miller, PA; Tiwari, R | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Cho, S; Franzblau, SG; Majewski, MW; Miller, MJ; Miller, PA | 1 |
Chinnapattu, M; Hameed P, S; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Nandishaiah, R; Patil, V; Puttur, J; Raichurkar, A; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Shinde, V; Solapure, S; Sriram, D | 1 |
Askri, M; Boudriga, S; Golz, C; Knorr, M; Mhiri, C; Nana, F; Sriram, D; Strohmann, C; Yogeeswari, P | 1 |
Peraman, R; Reddy, YP; Varma, RV | 1 |
Guo, H; Li, L; Liu, M; Lu, Y; Shen, W; Wang, B; Wang, M; Zhang, R; Zhang, T | 1 |
Huang, J; Li, L; Liu, H; Liu, M; Lu, Y; Wang, B; Wang, C; Wang, M; Zhang, R | 1 |
Aminabhavi, TM; Dixit, SR; Joshi, SD; Kirankumar, MN; Lherbet, C; Narayan, R; Raju, KV; Yang, KS | 1 |
Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cho, S; Franzblau, SG; Majewski, MW; Miller, MJ; Miller, PA; Tiwari, R | 1 |
Abouelhassan, Y; Bai, F; Burch, GM; Garrison, AT; Huigens, RW; Jin, S; Kallifidas, D; Luesch, H; Nguyen, MT; Norwood, VM; Rolfe, M | 1 |
Feng, L; Huang, J; Li, X; Liu, M; Lu, Y; Wang, B; Wang, M; Wu, Z; Yang, Y; Zhang, J | 1 |
Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Pancholia, S; Shah, P; Sridevi, JP; Sriram, D; Yogeshwari, P | 1 |
Daletos, G; Ebrahim, W; El-Neketi, M; Kalscheuer, R; Lewald, LI; Lin, W; Orfali, RS; Proksch, P; Rehberg, N | 1 |
Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Kumar, D; Sridevi, JP; Sriram, D; Vaja, MD; Yogeeswari, P | 1 |
Bharath, G; Debanjan, B; Gangagni Rao, A; Jitender Dev, G; Krishna Swaroop, D; Naresh Kumar, R; Narsaiah, B; Nishant Jain, S; Ravikumar, N | 1 |
Blair, PM; Mitchell, DA; Molloy, EM; Tietz, JI | 1 |
Lynch, AS; Ma, Z | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Chakraborti, AK; Kumar, A; Sriram, D; Tanwar, B; Yogeeswari, P | 1 |
Aminabhavi, TM; Dixit, SR; Joshi, SD; Kulkarni, VH; Lherbet, C; Nadagouda, MN | 1 |
Balaji, NV; Hari Babu, B; Murali Krishna Kumar, M; Purna Nagasree, K; Subbaraju, GV | 1 |
Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
Sankar, C; Umamatheswari, S | 1 |
Adhikari, C; Krishna, VS; Reshma, RS; Sharada, DS; Sriram, D; Vidyacharan, S | 1 |
Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
Bartůněk, P; Benada, O; Bogdanová, K; Ehn, M; Fišer, R; Kolář, M; Krásný, L; Křížek, T; Panova, N; Pohl, R; Pospíšil, J; Rejman, D; Šanderová, H; Sedlák, D; Seydlová, G; Šimák, O; Sudzinová, P; Večeřová, R; Vítovská, D; Zborníková, E | 1 |
Bernardino, AMR; Boechat, N; Dos Santos, MS; Faria, JV; Miguita, AGC; Vegi, PF | 1 |
Berscheid, A; Brötz-Oesterhelt, H; Chaidir, C; Daletos, G; Hartmann, R; Kalscheuer, R; Kassack, MU; Mokhlesi, A; Proksch, P; Rehberg, N; Stork, B; Stuhldreier, F; Sureechatchaiyan, P; Wesselborg, S; Wex, KW | 1 |
Coffey, A; Endersen, L; Fontinha, D; Jampilek, J; Machado, M; Pavić, K; Perković, I; Pospíšilová, Š; Prudêncio, M; Rimac, H; Zorc, B | 1 |
Cheng, XW; Fan, YL; Feng, LS; Wu, JB; Zhang, FZ | 1 |
Bimal, D; Bohra, K; Jain, R; Maity, J; Ponnan, P; Prasad, AK; Singh, B; Srivastava, S; Thirumal, M; Varma-Basil, M | 1 |
Fan, YL; Feng, LS; Gao, T; Huang, ZP; Jin, XH; Yu, HF; Zeng, ZG | 1 |
Cobine, PA; Ganji, S; Jacob, MR; Kakirde, KS; Khan, IA; Li, XC; Liles, MR; Mead, DA; Nasrin, S; Ravu, RR; Wang, M; Wu, CC | 1 |
Banerjee, A; Chakraborti, AK; Dhameliya, TM; Pancholia, S; Panda, D; Sriram, D; Tiwari, R | 1 |
Bhushan Tripathi, S; Chanda, D; Chaturvedi, AK; Khwaja, S; Kumar, BS; Negi, AS; Roy, S; Sachan, NK; Saikia, D; Shanker, K; Sharma, A; Thakur, JP; Verma, AK | 1 |
Ashok, D; Goud, GL; Manga, V; Ramesh, S; Reddy, VP; Saikrishna, B; Sriram, D; Yogeeswari, P | 1 |
Doležal, M; Jand'ourek, O; Kuneš, J; Navrátilová, L; Paterová, P; Vinšová, J; Zitko, J | 1 |
Eswaran, S; Narayanan, S; Shivarudraiah, P; Shruthi, TG; Subramanian, S | 1 |
Bai, L; Deng, JL; Gao, F; Lv, ZS; Wang, Y; Xu, Z; Zhang, F; Zhao, SJ | 1 |
AnkiReddy, S; Bharathi Reddy, K; Rao Sagurthi, S; Sabitha, G; Shiva Raju, K; Siva Krishna, V; Sriram, D | 1 |
Kantevari, S; Krishna, VS; Marvadi, SK; Sriram, D | 2 |
Cai, S; Fang, Z; Guo, Q; Huang, X; Li, Y; Lin, H; Lu, YJ; Sun, N; Tang, Z; Wong, KY; Wong, WL; Yuan, W | 1 |
Akhter, M; Alam, MM; Ali, S; Deora, GS; Krishna, VS; Sharma, K; Sriram, D; Tanwar, O; Zaman, MS | 1 |
Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
Bera, S; Mondal, D | 1 |
Barua, N; Blanchard, N; Chan, PK; Chan, ST; Hanquet, G; Ip, M; Lin, L; Ma, C; Qiu, Y; Shek, TL; Tsang, TF; Yang, X; Zhang, Y; Zuo, Z | 1 |
Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
Esaulkova, YL; Kantevari, S; Krishna, VS; Marvadi, SK; Muryleva, AA; Sinegubova, EO; Sriram, D; Tentler, DG; Volobueva, AS; Zarubaev, VV | 1 |
Ammeter, D; Idowu, T; Rossong, H; Schweizer, F; Zhanel, GG | 1 |
Augustynowicz-Kopeć, E; Bielenica, A; Chrzanowska, A; Dobrowolski, M; Głogowska, A; Roszkowski, P; Stępień, K; Struga, M; Szulczyk, D | 1 |
Bangalore, PK; Bollikanda, RK; Choudante, PC; Kantevari, S; Misra, S; Sridhar, B; Sriram, D; Vagolu, SK; Veeragoni, DK | 1 |
Krishna, VS; Sirim, MM; Sriram, D; Unsal Tan, O | 1 |
Chen, Q; Chen, WM; Hou, W; Li, Z; Lin, J; Lu, K; Xu, XF | 1 |
Duan, X; Huang, M; Kong, B; Nian, S; Peng, Y; Qin, J; Tan, X | 1 |
Abutaleb, NS; Alhashimi, M; Kassab, AE; Mayhoub, AS; Mohamed, KO; Seleem, MN; Shahin, IG; Taher, AT | 1 |
Dixit, PP; Haval, KP; Haval, NB; Kasare, SL; Khedkar, VM; Patil, PS; Rekha, EM; Sriram, D | 1 |
Cordeiro, R; Kachroo, M | 1 |
Berg, R; Dorst, A; Gademann, K; Gertzen, CGW; Gohlke, H; Gwerder, M; Sander, P; Schäfle, D; Schnell, SD; Zerbe, K | 1 |
Alexandrova, LA; Avdanina, DA; Boykova, YV; Efimenko, TA; Efremenkova, OV; Glukhova, AA; Jasko, MV; Karpenko, IL; Kochetkov, SN; Kolonitskaya, DP; Kost, NV; Negrya, SD; Nuraeva, GK; Shevchenko, OV; Solodinin, AP; Solyev, PN; Volkov, IA; Zhgun, AA | 1 |
Trotsko, N | 1 |
Alam, MA; Basnakian, AG; Frangie, MM; Gilmore, DF; Hansa, RK; Khan, MMK; Savenka, AV; Shelton, RS; Shuttleworth, SL; Smeltzer, MS | 1 |
Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
Chen, WM; Hou, W; Huang, MY; Lin, J; Meng, Y; Xu, XF; Yu, JH | 1 |
Chen, W; Ma, S; Song, D; Zhang, N; Zhang, P; Zhang, S | 1 |
Abugazleh, MK; Alam, MA; Ali, H; Gilmore, D; Raj Kc, H; Roy, S; Saleh, I | 1 |
Bora, A; Deka, B; Devi, MV; Dihingia, A; Pahari, P; Sarma, S; Sen, T; Singh, AK; Suri, M | 1 |
Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y | 1 |
Guo, XC; Huang, XH; Lu, YJ; Ser, HL; She, MT; Sun, N; Wong, WL; Zhang, YH; Zheng, BX; Zhong, DX | 1 |
Agrahari, AK; Rajkhowa, S; Sharma, A; Tiwari, VK | 1 |
Angeles-Solano, M; Brock, JW; Grosser, MR; Murphy, KE; Pugh, BA; Rao, AB; Wolfe, AL | 1 |
Carper, HT; Frank, MO; Mandell, GL; Sullivan, GW | 1 |
Dubois, J; Joly, JR | 1 |
Hamilton-Miller, JM | 1 |
Poole, MD | 1 |
Lang, R; Rubinstein, E; Shasha, B | 2 |
Guenounou, M; Nicolas, MH; Nordmann, P; Rouveix, E | 1 |
Cheong, I; Rahman, MZ; Tan, SC; Wong, YH; Zin, Z | 1 |
Kahana, LM; Spino, M | 1 |
Amyes, SG; Lewin, CS | 1 |
Howard, BM; Lewin, CS; Smith, JT | 1 |
Bartok, AE; Chiu, J; Deresinski, SC; Feigal, DF; Kemper, CA; Leedom, JM; McCutchan, JA; Meng, TC; Nussbaum, J; Tilles, JG | 1 |
Jones, DM | 1 |
Bamberger, DM; Fields, MT; Herndon, BL | 1 |
Deeter, RG; Gross, JS; Swanson, KA; Weinstein, MP | 1 |
Auckenthaler, R; Chuard, C; Herrmann, M; Lew, DP; Lucet, JC; Rohner, P; Waldvogel, FA | 1 |
Daza, R; de Letona, JM; Martinez Ruiz, R; Mendaza, P; Rodriguez Diaz, JC; Roman, F; Tebas, P | 1 |
Benson, CA; Kessler, HA; Pottage, JC; Trenholme, GM | 1 |
Maher, D | 1 |
Lang, R; Raz, R; Sacks, T; Shapiro, M | 1 |
Hadley, WK; Nassos, PS; Sanders, CA; Yajko, DM | 1 |
Darouiche, R; Hamill, R; Musher, D; Perkins, B; Tsai, S | 1 |
Auckenthaler, R; Herrmann, M; Lew, DP; Lucet, JC; Rohner, P; Waldvogel, FA | 1 |
McWhinney, PH | 1 |
Blakemore, PH; Drabu, YJ | 1 |
Chandler, MH; Korvick, JA; Muder, RR; Rapp, RP; Toler, SM | 1 |
Barker, JE; Farrell, ID | 1 |
Gerding, DN; Homann, S; Jensen, B; Johnson, S; Peterson, LR; Petzel, RA; Quick, JN; Shanholtzer, C; Sinn, L; Tenquist, J | 1 |
Bozzette, S; Chiu, J; Heseltine, PN; Leedom, J; McCutchan, JA; Nussbaum, J; Tilles, JG; Young, LS | 1 |
Dworkin, R; Kunz, S; Modin, G; Rich, R; Sande, M; Zak, O | 1 |
Lewin, CS; Smith, JT | 1 |
Kamerer, DB; Matador, A; Muder, RR; Rubin, J; Stoehr, G; Yu, VL | 1 |
Korting, HC; Lukacs, A | 1 |
Baltch, AL; Conroy, JV; Hammer, MC; Liebers, DM; Smith, RP | 1 |
Abrams, D; Becker, S; Jacobson, MA; Marks, SH; Mass, MM; Wurtz, RM | 1 |
Chambers, HF; Dworkin, RJ; Lee, BL; Sande, MA | 1 |
Baldelli, F; Fiorio, M; Moretti, A; Moretti, MV; Pasticci, MB; Pauluzzi, S | 1 |
Chadwick, M; Gaya, H; Nicholson, G | 1 |
Polk, RE | 1 |
Hoogeterp, JJ; Krul, AM; Mattie, H; Terporten, P; van Furth, R | 1 |
Barriere, SL; Kaatz, GW; Seo, SM | 1 |
Gutschik, E; Røder, BL | 1 |
Gordon, RC; Kumar, A; Wofford-McQueen, R | 1 |
Albrecht, LM; Barriere, SL; Kaatz, GW; Rybak, MJ; Seo, SM | 1 |
Rodgers, FG; Tzianabos, AO | 2 |
Baskerville, A; Featherstone, AS; Fitzgeorge, RB | 1 |
Traub, WH | 1 |
Bartels, H; Kunz, B; Rosenfeld, M; Ruschmeyer, HJ; Seydel, JK; Spannuth, G; Visser, K; Wempe, E | 1 |
Klastersky, J; Van der Auwera, P | 1 |
Joly, P; Van der Auwera, P | 1 |
Wall, RA | 1 |
Chin, NX; Neu, HC | 1 |
Easmon, C; Verity, L | 1 |
Cuevas, TA; Dworzack, DL; Horowitz, EA; Pugsley, MP; Sanders, CC; Sanders, WE | 1 |
Casal, M; González, J; Gutierrez, J; Ruiz, P | 1 |
Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N | 1 |
Pohlod, DJ; Saravolatz, LD; Somerville, MM | 1 |
Collins, CH; Uttley, AH | 1 |
Crane, JP; Easmon, CS | 1 |
Falkiner, FR; Jones, L; Keane, CT; Mooney, D; Moorhouse, EC; Mulvihill, TE | 1 |
Fitzgeorge, RB | 1 |
Moffie, BG; Mouton, RP | 1 |
Evans, CW; Gaunt, PN; Lambert, BE | 1 |
Havlichek, D; Pohlod, D; Saravolatz, L | 1 |
Henry, NK; McConnell, ME; Rouse, MS; Whitesell, AL; Wilson, WR | 1 |
Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE | 1 |
Erlendsdóttir, H; Gottfredsson, M; Gudmundsson, A; Gudmundsson, S | 1 |
Simonetti, MT; Tortoli, E | 1 |
Kaatz, GW; Kang, SL; McGrath, BJ; Rybak, MJ; Seo, SM | 1 |
Deshevoi, S; Efstratiou, A; George, RC; Jahkola, M; Maple, PA; Rikushin, Y; Tseneva, G; Vuopio-Varkila, J | 1 |
Caillon, J; Drugeon, HB; Juvin, ME | 1 |
Nielsen, PE; Thelle, T; Tvede, M | 1 |
Mills, K; Wanger, A | 1 |
Kasatkina, IV; Ryzhko, IV; Shcherbaniuk, AI | 1 |
Cuevas, LE; Hart, CA; Kazembe, P; Mughogho, GK; Tillotson, GS | 1 |
Artenstein, AW; Fritzinger, D; Gasser, RA; Hadfield, TL; McEvoy, PL; Skillman, LP | 1 |
Allen, NB; Corey, GR; Darling, TN; Kamino, H; Murray, JC; Sidhu-Malik, N | 1 |
Greten, T; Hautmann, H; Huber, RM; Trauner, A | 1 |
Akay, MA; Kiliç, E; Köseoğlu, F | 1 |
Ahn, CH; Brown, BA; Dunbar, D; Dunlap, R; Murphy, DT; Onyi, G; Wallace, RJ | 1 |
Borgstein, J; Cortes, R; Sada, E | 1 |
Howard, BM; Pinney, RJ; Smith, JT | 1 |
Gilbert, C; Hussein, A; Meisenberg, B; Perfect, J; Peters, WP; Ross, M; Vredenburgh, J | 1 |
Dusart, G; Simeon De Buochberg, M; Ximenes, E; Zuccarelli, M | 1 |
Gordon, SM; Havlik, JA; Heifets, L; Horsburgh, CR; McGowan, JE; Metchock, B; Peloquin, CA; Thompson, SE | 1 |
Fox, R; Gillespie, SH; Kennedy, N; Kisyombe, GM; Ngowi, FI; Ramsay, AR; Saruni, AO; Uiso, LO | 1 |
Johnson, CC; Levison, ME; Livornese, LL; Osborne, AJ; Pitsakis, PG; Whitman, MS; Zausner, A | 1 |
Hjelm, U; Hoffner, SE; Källenius, G | 1 |
Hartigan, ER; Kurland, G; Noyes, BE; Orenstein, DM; Pattishall, EN; Yu, VL | 1 |
Clark, JA; Margolis, DM | 1 |
Brosgart, C; Charlebois, E; Gary, D; Hadley, WK; Jacobson, MA; Northfelt, D; Sanders, CA; Yajko, D | 1 |
Francis, G; Nimmo, GR; Turnidge, JD | 1 |
Blondeau, JM; Yaschuk, Y | 1 |
Asnis, DS; Bresciani, AR; Cohn, M | 1 |
Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP | 1 |
Daoud, EG; Flexner, C; Goodman, SN; Hartert, TV; Heldman, AW; Kowalski, TE; Lietman, PS; Petty, BG; Pompili, VJ; Ray, SC; Sisson, SD; Tidmore, WC; vom Eigen, KA | 1 |
Blecker, DL; Ferraro, AL; Mortensen, JE; Phengvath, C | 1 |
Berger, L; Curram, J; Fox, R; Gillespie, SH; Gutmann, J; Kennedy, N; Kisyombe, GM; Ngowi, FI; Ramsay, AR; Sam, N; Saruni, AO; Tillotson, G; Uiso, LO; Yates, M | 1 |
Paton, AW; Paton, JC; Talbot, UM | 1 |
Meng, X; Nightingale, CH; Pei, Y; Quintiliani, R | 1 |
Pulverer, G; Rump, A; Schierholz, JM | 1 |
Brabant, WH; Britschgi, TB; Cangelosi, GA; Wallis, CK | 1 |
Fujimoto, Y; Fukuuchi, F; Hida, M; Hiraga, S; Satoh, T | 1 |
Richards, RM; Xing, JZ | 1 |
Coker, RJ; Fisher, M; Tomlinson, DR | 1 |
Brehm, T; Gollard, R; McMillan, R; Meisenberg, B; Miller, W | 1 |
Bespalova, IA; Bugaeva, OK; Goncharov, EK; Makarovskaia, LN; Malsova, NN; Pavlovich, NV; Ryzhkova, VV; Zurabian, VA | 1 |
Barclay, ML; Begg, EJ; Chambers, ST; Peddie, BA | 1 |
Chang, JS; Huang, SC; Liang, YS; Soong, HK | 1 |
Erdem, I; Korten, V; Murray, BE | 1 |
Branley, J; Gottlieb, T; Wolfson, C | 1 |
Flisch, CW; Santa, DD; Zuber, C | 1 |
Borderas, F; Delgado, J; Gallardo, JA; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A | 1 |
Garcia, R; Raad, I | 1 |
Bloch, KC; Jacobs, R; Nadarajah, R | 1 |
Cortés-Funes, H; Gómez, C; Hidalgo, M; Hitt, R; Hornedo, J; Lumbreras, C; Perea, S; Ruiz, A; Trigo, JM | 1 |
Bahl, D; Gialanella, P; Leviton, I; Liu, W; Miller, DA; Miller, MH; Perkins, R; Wolin, MJ | 1 |
Batmanov, VP; Iliukhin, VI | 1 |
Killian, AD; Pendland, SL; Rodvold, KA; Woodward, JG | 1 |
Benator, DA; Gordin, FM; Kan, V | 1 |
Hoshino, E; Iwaku, M; Kota, K; Kurihara-Ando, N; Sato, I; Sato, M; Uematsu, H | 1 |
Matsiota-Bernard, P; Nauciel, C; Onody, C | 1 |
Fuursted, K | 1 |
Padeĭskaia, EN | 1 |
Baraia-Etxaburu, J; Cisterna, R; Malero, P; Muñoz, J; Santamaría, JM; Teira, R; Unzaga, MJ | 1 |
Canawati, HN; Montgomerie, JZ; Schick, DG | 1 |
Baiocchi, P; Carfagna, P; Cassone, M; Galiè, M; Santini, C; Tarasi, D; Venditti, M | 1 |
Chryssouli, Z; Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P; Sambatakou, H | 1 |
Blatter, M; Frei, R; Ochsner, PE; Widmer, AF; Zimmerli, W | 1 |
Gottlieb, T; Mitchell, D | 1 |
Appel, RG; Cowan, RJ; Houston, TK; Peacock, JE | 1 |
Hof, H; Kretschmar, M; Laufen, H; Meyer, A; Nichterlein, T; Schadt, A; Wildfeuer, A | 1 |
Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
Cavallo, JD; Fabre, R; Martet, G; Nicolas, P | 1 |
Ansorg, R; Fabry, W; Schmid, EN | 1 |
Barber, TW; Currier, J; Ellner, JJ; Hafner, R; Hojczyk, P; Hooton, TM; Jacobs, MR; Limjoco, M; Parenti, DM; Powderly, WG; Simpson, G; van der Horst, C; Williams, PL | 1 |
Bingen, E; Bonacorsi, S; Fitoussi, F; Lhopital, S | 1 |
Dubois, J; St-Pierre, C | 1 |
Dalhoff, A; Ruckdeschel, G | 1 |
Chang, SC; Chang, YL; Fang, CT; Hsieh, WC; Hsueh, PR; Luh, KT | 1 |
Bergh, K; Løseth, K; Persen, L; Witsø, E | 1 |
Donati, L; Quadri, P; Reiner, M | 1 |
Efron, A; Lopardo, H; Lucero, NE | 1 |
Agalar, C; Turkyilmaz, R; Usubutun, S | 1 |
Koromihis, G; Libman, M; MacLean, JD; Semret, M; Ward, BJ | 1 |
Javaloyas de Morlius, M; Monreal Portella, M | 1 |
Bangsborg, JM; Høiby, N; Nielsen, K | 1 |
Khorasheh, S; Lemieux, C; Raboud, JM; Salit, I; Shafran, SD; Singer, J; Thorne, A; Tsoukas, CM; Wu, AW | 1 |
Arcediano, A; Cortés-Funes, H; Gomez-Martin, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Rodriguez, M; Salazar, R; Solá, C; Valentí, V | 1 |
Boussougant, Y; Lasry, S; Marais, A; Pouchot, J; Simon, J; Vinceneux, P | 1 |
Arreaza, L; de la Fuente, L; Fernández, S; Vázquez, JA | 1 |
Bajaksouzian, S; Jacobs, MR; Joloba, ML | 1 |
Hara, T; Ikejima, H; Kaku, M; Kanemitsu, K; Kunishima, H; Shimada, J; Shoji, Y; Takemura, H; Terakubo, S; Yamamoto, H | 1 |
Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
Beeck, A; Boos, M; Fluit, AC; Hafner, D; Köhrer, K; Perdikouli, M; Scheuring, S; Schmitz, FJ; Verhoef, J; Von Eiff, C | 1 |
Bandera, A; Degli Esposti, A; Ferrario, G; Franzetti, F; Gori, A; Marchetti, G; Rossi, MC; Tocalli, L | 1 |
Beeck, A; Fluit, AC; Perdikouli, M; Schmitz, FJ | 1 |
Jiang, Q; Taylor, DE; Wang, G; Wilson, TJ | 1 |
Araj, GF; Zouain, MG | 1 |
Domínguez, L; Fernández-Garayzábal, JF; Latre, MV; Moreno, MA; Rodríguez, AA; Vela, AI | 1 |
König, DP; Münnich, U; Rütt, J; Schierholz, JM | 1 |
Pinney, RJ; Wickens, HJ | 1 |
Antoniadis, A; Ntoutsou, K; Sofianou, D; Souliou, E; Trakatelli, C; Tsakris, A | 1 |
Carabias, ML; Cervera, LA; entelles, ML; García-Navas, BL | 1 |
Berman, EL; Bersoff-Matcha, S; Cerva, D; Druckenbrod, G; Earls, J; Fatteh, N; Hanfling, D; Harper, S; Mayer, TA; Murphy, C; Napoli, A; Nayyar, A; Nguyen, M; Pauze, D; Rosenthal, J | 1 |
Brown, K | 1 |
Marks, PJ; Neal, KR | 1 |
Alcalá, B; Arreaza, L; Salcedo, C; Vázquez, JA | 1 |
Avallone, F; Bertone, C; Maniscalco, P; Rivera, F; Urgelli, S | 1 |
Chopra, I; Miller, K; O'Neill, AJ | 1 |
Woo, PC; Yuen, KY | 1 |
Braun, J; Sieper, J | 1 |
Baiocchi, P; Cassone, M; Falcone, M; Pavoni, GL; Serra, P; Tarasi, A; Venditti, M | 1 |
Grohs, P; Gutmann, L; Kitzis, MD | 1 |
Belli, ML; Cruciani, M; Fenu, ML; Manno, G; Romano, L; Ugolotti, E | 1 |
de la Campa, AG; Martín-Galiano, AJ | 1 |
Duĭsenova, AK; Kurmanova, GM; Kurmanova, KB | 1 |
Freire, M; Graña, G; Losada, I; Rita, M | 1 |
Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
Brennan, RE; Samuel, JE | 1 |
Charalambous, BM; Gillespie, SH | 1 |
Akinci, E; Aksaray, S; Balaban, N; Bodur, H; Colpan, A; Erbay, A; Yetener, V | 1 |
Contag, PR; Francis, KP; Kadurugamuwa, JL; Kimura, R; Purchio, T; Sin, LV; Yu, J | 1 |
Kayaçetin, E; Saritaş, U; Türegen, A | 1 |
Cabellos, C; Domenech, A; Gudiol, F; Liñares, J; Ribes, S; Tubau, F; Viladrich, PF | 1 |
Aktaş, E; Ayyildiz, A; Ertek, M; Parlak, M; Yazgi, H | 1 |
Inoue, M; Li, Q; Nagata, K; Park, AM; Sato, EF; Shimono, K; Tamura, T | 1 |
Ibrisim, E; Kutsal, A; Ocal, A; Ozaydin, M; Ulusan, V; Yavuz, T | 1 |
Bergiers, C; Derue, G; Dujardin, JP; Frippiat, F; Michel, C | 1 |
Bergmann, JF; Jarrin, I; Mahé, I; Mai, T; Mouly, S; Sellier, P | 1 |
Carbonell, D; Fernández-Olivera, N; García-García, I; López-Saura, PA; Machado-Molina, D; Milanés-Virelles, MT; Suárez-Méndez, R; Valdés-Quintana, M; Valenzuela-Silva, CM | 1 |
Egawa, H; Miyauchi, T; Tanaka, S; Tokunaga, Y; Yamane, T | 1 |
Fraser, A; Gafter-Gvili, A; Leibovici, L; Paul, M | 2 |
Bose, M; Dam, T; Isa, M | 1 |
Andes, DR; Chin, JK; Cirz, RT; Craig, WA; de Crécy-Lagard, V; Romesberg, FE | 1 |
Abo, M; Fujimura, M; Honjyo, C; Nakao, S; Nishizawa, Y; Tagami, A; Yasui, M | 1 |
Baek, DH; Chung, MJ; Ha, NJ; Kang, BY; Kang, JY; Kim, K; Kim, SD; Shin, EA; Yim, DS; Yun, JH | 1 |
Bhusal, Y; Shiohira, CM; Yamane, N | 1 |
Berdal, JE; Bjørnholt, JV; Gulbrandsen, P; Mowinckel, P; Skråmm, I | 1 |
Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW | 1 |
Empel, J; Hryniewicz, W; Kadłubowski, M; Skoczyńska, A | 1 |
D'Costa, VM; Hughes, DW; McGrann, KM; Wright, GD | 1 |
Bergstrand, IC; Björkman, S; Heijl, A; Höglund, P; Magnusson, M; Roth, B | 1 |
Feldman, C; Francois Venter, WD; Joffe, BI; Panz, VR | 1 |
Heym, B; Jouve, F; Lemoal, M; Lortat-Jacob, A; Nicolas-Chanoine, MH; Veil-Picard, A | 1 |
Anguita-Alonso, P; Jacofsky, DJ; Osmon, DR; Patel, R; Piper, KE; Rouse, MS | 1 |
Drobniewski, FA; Krüüner, A; Yates, MD | 1 |
Baum, GL; Daniele, B; Kramer, MR; Lavy, A; Priess, R; Raz, M; Shitrit, AB; Shitrit, D; Shlomi, D | 1 |
Cevikbaş, A; Erçağ, E; Erten, N; Göçer, P; Gürbüz, B; Gürer, US; Karan, A; Rayaman, E; Uzer, A | 1 |
Alp, E; Aygen, B; Doganay, M; Durak, AC; Koc, RK; Sumerkan, B; Yildiz, O | 1 |
Boger, MS; Collins, CA; Mason, L; Raad, II; Sherertz, RJ | 1 |
Liukshina, EIu; Ryzhko, IV; Shcherbaniuk, AI; Smorodinova, IuV | 1 |
Buffet, PA; Darie, H; Freitag, S; Gounod, N; Le Guern, AS; Therby, A; Van Der Vliet, D | 1 |
Durdu, YB; Kutlu, SB; Nazlican, O; Ozdemir, R; Sengöz, G; Yaşar, KK | 1 |
Arslan, H; Cokaloğlu, S; Demiroğlu, YZ; Gül, U; Güvel, S; Turunç, T; Uncu, H | 1 |
Gardner, P | 1 |
Biscione, F; Brezzo, C; Cecchini, D; Costa, N; Orduna, T; Quinteros, M | 1 |
Goodman, CD; McFadden, GI; Su, V | 1 |
Biswas, S; Raoult, D; Rolain, JM | 1 |
Arslan, H; Azap, OK; Serefhanoğlu, K; Turan, H; Uncu, H | 1 |
Jalava, J; Kuipers, OP; Savijoki, K; Varhimo, E; Varmanen, P | 1 |
Edwards, CM; Fitzpatrick, RW | 1 |
Alvarez, PD; Ballester, SJ; Cugat, RB; Mann, G; Mei-Dan, O; Steinbacher, G | 1 |
Gao, H; Lindholt, JS; Lund, L; Prag, J; Sandermann, J | 2 |
Bax, HI; Gyssens, IC; Rietveld, AP; van Veelen, ML | 1 |
Borghero, C; Castaman, G; Corso, C; Madeo, D; Rodeghiero, F; Ruggeri, M; Scognamiglio, F; Visco, C | 1 |
Coban, AY; Darka, O; Durupinar, B; Tanyel, E; Tasdelen Fisgin, N; Tulek, N | 1 |
Ablordey, A; Imposo, DB; Lefevre, L; Mahema, RL; Meyers, WM; Phanzu, DM; Portaels, F; Suykerbuyk, P | 1 |
Banks, J; Campbell, IA; Gelder, CM; Jenkins, PA; Prescott, RJ; Smith, AP | 1 |
Hill, AT; Laurenson, IF; Murray, MP | 1 |
Aoshima, M; Goto, H; Ishii, H; Kato, A; Kato, J; Kurai, D; Mikura, S; Saraya, T; Shimura, C; Takata, S; Wada, H; Watanabe, M; Yamada, A; Yamamoto, M; Yasutake, T; Yokoyama, T | 1 |
Becket, E; Bui, A; Hong, J; Kim, K; Liu, A; Miller, JH; Sitz, D; Solaimani, P; Tamae, C; Tran, KP; Yang, H | 1 |
Blanchemain, N; Chai, F; Haulon, S; Hildebrand, HF; Kirkpatrick, CJ; Krump-konvalinkova, V; Laurent, T; Martel, B; Morcellet, M; Neut, C | 1 |
Benet, LZ; Frassetto, LA; Huang, Y; Zheng, HX | 1 |
Blázquez, J; López, E | 1 |
Agudo, S; Alarcón, T; Cibrelus, L; López-Brea, M; Martínez, MJ; Urruzuno, P | 1 |
Boehler, A; Gaspert, A; Irani, S; Lienhardt, B; Weishaupt, D | 1 |
Chisholm, SA; Owen, RJ | 1 |
Li, D; Liu, Q; Song, X; Xu, C; Yang, X; Zhang, J | 1 |
Hashemi, SH; Keramat, F; Mamani, M; Ranjbar, M; Zeraati, F | 1 |
Klein, M; Pfister, HW | 1 |
Appelbaum, PC; Ednie, LM; Lin, G; Pankuch, GA | 1 |
Athanasiou, H; Ioannou, S; Karadima, D; Pneumaticos, S; Pontikis, J; Sipsas, NV; Zormpala, A | 1 |
Aathithan, S; French, GL | 1 |
Bandhu, A; Chanda, PK; Jana, B; Lee, CY; Mondal, R; Sau, S | 1 |
Castillo, R; Cepeda, D; Chacaltana, J; Espinosa, B; Espinoza, N; González, S; Guillen, A; Hall, ER; Maves, RC; Meza, R; Núñez, G; Sánchez, L | 1 |
Aoyama, K; Horiuchi, M; Komatsu, M; Miyahara, E; Miyanohara, H; Nishi, J; Nishie, M; Oda, H; Takeuchi, M; Takeuchi, T; Takumi, S; Yoshiie, K | 1 |
Jones, WL; McKittrick, L; Stewart, PS; Sutton, MP | 1 |
Campbell, PJ; Cowan, LS; Dalton, TL; Hooks, DP; Metchock, B; Morlock, GP; Plikaytis, BB; Posey, JE; Sikes, RD; Starks, AM | 1 |
Brandão, AP; Brandileone, MC; de Paiva, MV; Gorla, MC; Lemos, AP; Salgueiro, VC; Vázquez, JA | 1 |
Didier, JP; Hooper, DC; Huggler, E; Kelley, WL; Lew, DP; Vaudaux, P; Villet, R | 1 |
Ambrose, PG; Bhavnani, SM; Caws, M; Chau, TT; Dung, NT; Farrar, J; Hammel, JP; Hien, TT; Kulawy, R; Mai, PP; Reynolds, DK; Thwaites, GE; Török, ME; Van Wart, SA | 1 |
Devaraj, SN; Girija, EK; Kalkura, SN; Raja, SB; Savithri, K; Sridevi, TS; Thamizhavel, A; Vani, R | 1 |
Carr, R; Dayal, A; Gandhi, D; Raghavan, D; Seear, M; Sharma, N | 1 |
Abbasi, S; Ikram, A; Khalid, MM; Manzar, MA; Sattar, A; Satti, L | 1 |
Fraser, A; Gafter-Gvili, A; Leibovici, L; Paul, M; Zalmanovici Trestioreanu, A | 2 |
Duchin, JS; Kay, MK; Perti, TR | 1 |
Hiyoshi, A; Kato, C; Miyahara, K; Ohshima, Y | 1 |
Ben Jemaa, M; Hammami, A; Koubaa, M; Ktari, S; Mahjoubi, F; Mhiri, MN; Mnif, B | 1 |
Holmberg, A; Mörgelin, M; Rasmussen, M | 1 |
Blanchemain, N; Haulon, S; Hildebrand, HF; Jean-Baptiste, E; Martel, B; Neut, C | 1 |
Chitnis, DS; Hemvani, N; Patidar, V | 2 |
Bircher, AJ; Brož, P; Grize, L; Harr, T; Hecking, C; Jaeger, KA; Scherer, K | 1 |
Balabanova, Y; Drobniewski, F; Evans, CA; Kummik, T; Mitchell, S; Nikolayevskyy, V; Toit, K | 1 |
Deng, Y; Luo, J; Lv, W; Sun, Y | 1 |
Baldan, HM; Brunetti, IL; Campos, ML; Davanço, MG; de Pontes Machado, DV; Filho, MA; Padilha, EC; Peccinini, RG; Pires, RV | 1 |
Mehrani, M; Mortaz-Hejri, S; Sadeghipour, P; Yousefi-Nooraie, R | 1 |
Chatsuwan, T; Nuchprayoon, S; Sungpradit, S | 1 |
Çörekli, E; Eşiyok, A; Köseoğlu, K; Öncü, S; Öztürk, B; Sakarya, S; Saylak, Ö | 1 |
Gryllos, I; Toukoki, C | 1 |
Babbitt, JT; Campuzano, S; Churchill, BM; Gonzalez, R; Haake, DA; Halford, C; Hu, B; Liu, J; Wang, J | 1 |
Shen, J; Wang, S; Wang, Y; Wu, C; Wu, Y | 1 |
Hassani, M; Nozadi, MS; Taghvaee, MR | 1 |
Ekin, IH; Ilhan, Z; Solmaz, H | 1 |
Hwang, S; Jeon, B; Ryu, S | 1 |
Asher, LJ; Goldberg, AS; Kim, RB; Tirona, RG; Van Uum, SH | 1 |
Amores Arriaga, MB; Bucar Barjud, M; Gómez del Valle, C; Josa Laorden, C; Pérez Calvo, JI; Torralba Cabeza, MA | 1 |
Isaacs, J; Pullan, RD; Whelan-Johnson, S | 1 |
Athan, E; Callan, P; Friedman, ND; Hughes, AJ; Khajehnoori, M; McDonald, A; O'Brien, DP; Rahdon, R | 1 |
Bertram, R; Götz, F; Leibig, M; Ohlsen, K; Schäfer, T; Yu, W | 1 |
Dhawan, B; Gadepalli, R; Mukhopadhyay, K; Singh, M | 1 |
Celikel, C; Cetinel, S; Dulger, GA; Imeryuz, N; Kabasakal, L; Kan, B; Orun, O; Toklu, HZ; Yuksel, M | 1 |
Cars, O; Forsberg, P; Giske, CG; Hickman, RA; Lagerbäck, P; Tängdén, T | 1 |
Al-Ahmad, A; Ameen, H; Anderson, AC; Hellwig, E; Karygianni, L; Pelz, K; Spitzmüller, B; Wittmer, A | 1 |
Altena, R; de Wit, H; Folkeringa, R; Hoogendoorn, M; van Roon, E | 1 |
Gribakina, OG; Kolyvanov, GB; Novitskaia, IaG; Seredenin, SB; Smirnov, VV; Zherdev, VP | 1 |
García, P; Gutiérrez, D; Martínez, B; Rodríguez, A; Ruas-Madiedo, P | 1 |
Enriquez, RP; Lahra, MM | 1 |
Athan, E; Callan, P; Cowan, R; Friedman, ND; Fyfe, J; Hughes, AJ; McDonald, A; O'Brien, DP | 1 |
Bharate, JB; Bharate, SB; Joshi, P; Khan, IA; Kumar, A; Sharma, S; Singh, S; Vishwakarma, RA; Wani, A | 1 |
Forsblom, E; Järvinen, A; Ruotsalainen, E | 1 |
Aranda, J; Barbé, J; Bou, G; Cortés, P; Jara, LM | 1 |
Bravo-Toncio, C; Chávez, FP; Guiliani, N; Ortiz-Severín, J; Varas, M | 1 |
Huffam, S; O'Brien, DP | 1 |
Amornchai, P; Day, NPJ; Langla, S; Limmathurotsakul, D; Peacock, SJ; White, NJ; Wuthiekanun, V | 1 |
Banerjee, A; Delicata, M | 1 |
Leppilahti, J; Niinimäki, T; Ohtonen, P; Puhto, AP; Puhto, T; Syrjälä, H | 1 |
Alves, TM; Barbosa Pauletti, R; de Sousa Moura Souto, M; Heinemann, MB; Lage, AP; Minharro, S; Pinto da Silva Mol, J; Reinato Stynen, AP; Seles Dorneles, EM | 1 |
Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
Hamad, T; Hellmark, B; Nilsdotter-Augustinsson, Å; Söderquist, B | 1 |
Colquhoun, JM; Dunman, PM; Wozniak, RA | 1 |
Davies, HA; Garamus, VM; Gorniak, T; Hilpert, K; Mikut, R; Reischl, M; Rosenhahn, A; von Gundlach, AR | 1 |
Amer, R; Eiger-Moscovich, M; Kramer, M; Oray, M; Tabbara, KF; Tugal-Tutkun, I | 1 |
Chua, KL; Hsu, LY; Kang, ET; Leong, DT; Li, M; Neoh, KG; Xu, L; Yuan, L | 1 |
Balmelli, C; Battegay, M; Dangel, M; Elzi, L; Frei, R; Jakob, M; Schaefer, DJ; Tschudin-Sutter, S; Weisser, M; Widmer, AF | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
Allnutt, JC; Bacon, J; Bottley, G; Doris, KS; Hatch, KA; Hendon-Dunn, CL; Marriott, AA; Marsh, PD; Taylor, SC; Thomas, SR; Watson, RJ | 1 |
Dolapci, I; Karahan, ZC; Ocal, DN; Ozmen, BB; Tekeli, A | 1 |
Billman, AS; Duwve, JM; McMahan, DA; Pitcher, ED; Pontones, PR; Richards, SM; Waldron, MR | 1 |
Batty, KT; Clark, B; Davis, TM; Dyer, J; Knippenberg, B; Manning, L; Page-Sharp, M; Salman, S | 1 |
Gonzalez-Juarrero, M; Jackson, M; Lee, RE; Li, W; North, EJ; Obregón-Henao, A; Schnappinger, D; Wallach, JB | 1 |
Hwang, KT; Kim, B; Lee, Y; Pai, H | 1 |
Jung, JA; Kaisar, N; Parvez, MM; Shin, HJ; Shin, JG | 1 |
Churchward, CP; da Silva, RAG; Eleftheriadou, O; Griffin, R; Karlyshev, AV; Longman, MR; Ryan, A; Snabaitis, AK | 1 |
Hsieh, TC; Hsueh, PR; Jean, SS; Ning, YZ | 1 |
Al-Busaidi, I; Boggild, AK; Wong, D | 1 |
Daali, Y; Desmeules, JA; Marsousi, N; Rudaz, S | 1 |
Abdelbacki, AMM; El-Gebaly, RH; Fadel, MA; Mohamed, SA | 1 |
Clifton, DA; Crook, DW; Iqbal, Z; Niehaus, KE; Peto, TEA; Smith, EG; Walker, AS; Walker, TM; Wilson, DJ; Yang, Y; Zhu, T | 1 |
Choe, KW; Kim, KH; Lee, H; Lee, K; Seo, Y | 1 |
Beenken, KE; Courtney, HS; Haggard, WO; Jennings, JA; Smeltzer, MS; Wells, CM | 1 |
de Moraes, C; Dias, UJ; Gorla, MC; Lemos, AP; Pinhata, JMW | 1 |
Messner, T; Schjøtt, J | 1 |
Blaskovich, MAT; Cooper, MA; Gong, Y; Kavanagh, A; Ramu, S | 1 |
Bae, IG; Cho, OH; Choi, SH; Chong, YP; Kang, KC; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, MS; Lee, SO; Lee, YM; Moon, C; Park, KH; Park, SY; Ryu, BH; Woo, JH | 1 |
Goffin, E; Jacques, N; Lancellotti, P; Musumeci, L; Oury, C; Pirotte, B; Servais, L | 1 |
Epps, KL; Epps, QJ; Young, DC; Zobell, JT | 1 |
Balada-Llasat, JM; Evans, CA; Gelaw, B; Kelley, HV; Shibabaw, A; Tesfaye, E; Tessema, B; Torrelles, JB; Wang, SH | 1 |
Aubry, A; Bleibtreu, A; Fourniols, E; Funck-Brentano, C; Jaureguiberry, S; LLopis, B; Tissot, N; Zahr, N | 1 |
Amini, S; Feizabadi, MM; Feysia, SG; Hamzelou, G; Hasan-Nejad, M; Karami-Zarandi, M; Kardan-Yamchi, J; Kazemian, H | 1 |
Li, T; Ma, X; Shi, W; Zhang, Y; Zheng, X | 1 |
Almuwallad, OK; Barnawi, AI; Kassarah, KA; Kordy, FN | 1 |
Hogan, TR; Lahra, MM | 1 |
Cirnski, K; Coetzee, J; Herrmann, J; Müller, R | 1 |
Bennett, DE; Cafferkey, MT; Cunney, RJ; Meyler, KL | 1 |
Aubry, A; Bleibtreu, A; Chauvin, C; Comets, E; Fourniols, E; Funck-Brentano, C; Jaureguiberry, S; Llopis, B; Noe, G; Tissot, N; Urien, S; Zahr, N | 1 |
Bai, X; Borrow, R; Clark, SA; Lee-Jones, L; Lekshmi, A; Lucidarme, J; Walker, A; Walsh, L; Willerton, L | 1 |
Jokanovic, M; Kadija, M; Korica, S; Ladjevic, N; Milovanovic, D; Simic, M; Sreckovic, S; Vracevic, D | 1 |
Barak Levitt, J; Barmatz, S; Dalal, A; Fisch-Gilad, S; Hackett, A; Hodak, E; Kremer, N; Levi, A; Pavlovsky, L; Sherman, S; Taieb, Y; Yahav, D | 1 |
Bhat, SG; Kumar, RA; Kurthkoti, K; Nandicoori, VK; Natesh, R; Naz, S; Salini, S | 1 |
Mehra, S; Nag, A | 1 |
Al-Faifi, J; Ibrahim, ME | 1 |
Ebrahimzadeh, F; Gholami, S; Jafari-Sales, A; Rostami, A; Zadeh, FA | 1 |
Allen, L; Bartash, R; Cowman, K; Fauvel, D; Guo, Y; Minamoto, GY; Nnani, DU; Patel, S; Vukelic, S | 1 |
Pintarić, S; Štritof, Z; Tumpa, A | 1 |
Borghardt, JM; Braun, C; Himstedt, A; Wicha, SG | 1 |
Abd Algaffar, SO; Khalid, SA; van de Sande, WWJ; Verbon, A | 1 |
Alorabi, M; Ejaz, U; Khoso, BK; Mahmoud, SF; Sohail, M; Uddin, F; Youssef, M | 1 |
Chen, X; Perera, HA; Wu, B; Yan, M | 1 |
Abay, S; Akar, M; Aydin, F; Balkan Bozlak, CE; Baykal, A; Buyuk, E; Buyuk, F; Celebi, O; Celik, E; Coskun, MR; Durhan, S; Ersoy, Y; Gulmez Saglam, A; Karakaya, E; Kayman, T; Otlu, S; Sahin, M; Saticioglu, IB | 1 |
Chatupheeraphat, C; Eiamphungporn, W; Luk-In, S; Peamchai, J; Yainoy, S | 1 |
Campolattano, N; D'Abrosca, G; De Chiara, I; De Siena, B; Della Gala, M; Goff, A; Marasco, R; Muscariello, L; Russo, L; Sacco, M; Waddell, SJ | 1 |
35 review(s) available for ciprofloxacin and rifampin
Article | Year |
---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recently reported biological activities of pyrazole compounds.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Humans; Pyrazoles | 2017 |
Fluoroquinolone derivatives and their anti-tubercular activities.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2018 |
Recent advances of imidazole-containing derivatives as anti-tubercular agents.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2018 |
Fluoroquinolone-isatin hybrids and their biological activities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Antiviral Agents; Fluoroquinolones; Humans; Isatin; Structure-Activity Relationship | 2019 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Antitubercular properties of thiazolidin-4-ones - A review.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Structure-Activity Relationship; Thiazolidines; THP-1 Cells; Vero Cells | 2021 |
Emerging impact of triazoles as anti-tubercular agent.
Topics: Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis | 2022 |
Drug-drug interactions with ciprofloxacin and other fluoroquinolones.
Topics: Antacids; Caffeine; Ciprofloxacin; Cyclosporins; Drug Interactions; Humans; Intestinal Absorption; Rifampin; Theophylline | 1989 |
The chemoprophylaxis of meningococcal infection.
Topics: Anti-Bacterial Agents; Carrier State; Ceftriaxone; Ciprofloxacin; Half-Life; Humans; Meningococcal Infections; Pharynx; Rifampin; Risk Factors | 1988 |
[Esophagomediastinal fistulae as a rare complication of tuberculosis in an HIV-infected patient].
Topics: AIDS-Related Opportunistic Infections; Ciprofloxacin; Drug Therapy, Combination; Esophageal Fistula; Ethambutol; Fistula; HIV-1; Humans; Male; Mediastinal Diseases; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node | 1994 |
Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
Topics: Adolescent; Adult; Bacterial Vaccines; Canada; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Communicable Disease Control; Female; Humans; Infant; Infant, Newborn; Meningococcal Infections; Meningococcal Vaccines; Pregnancy; Public Health; Rifampin; Vaccination | 1994 |
[A case of toxic shock syndrome (TSS) induced by methicillin-resistant staphylococcus aureus (MRSA) presenting as acute renal failure with disseminated intravascular coagulation].
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Bacterial Toxins; Ciprofloxacin; Disseminated Intravascular Coagulation; Enterotoxins; Female; Humans; Methicillin Resistance; Rifampin; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Superantigens | 1996 |
[A case of arthritis of the wrist caused by Mycobacterium marinum. Review of the literature].
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Arthritis, Infectious; Ciprofloxacin; Clarithromycin; Debridement; Drug Therapy, Combination; Female; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Wrist Joint | 1996 |
Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Breast Neoplasms; Ciprofloxacin; Drug Resistance, Microbial; Female; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Liver Transplantation; Male; Meningitis, Bacterial; Middle Aged; Minocycline; Pneumonia, Bacterial; Rifampin; Sepsis; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Mycobacterium szulgai infection of the lung: case report and review of an unusual pathogen.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Radiography; Rifampin | 1997 |
[Value of ciprofloxacin in the therapy of tuberculosis and other mycobacterioses].
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections; Ofloxacin; Rifampin | 1997 |
Gallium-67-citrate scanning of renal parenchymal malacoplakia.
Topics: Anti-Infective Agents; Ascorbic Acid; Ciprofloxacin; Citrates; Female; Gallium; Gallium Radioisotopes; Humans; Kidney Diseases; Malacoplakia; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Rifampin | 1998 |
Successful treatment of disseminated Mycobacterium szulgai infection with ciprofloxacin, rifampicin, and ethambutol.
Topics: Adolescent; Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Humans; Male; Middle Aged; Mycobacterium Infections; Nontuberculous Mycobacteria; Rifampin | 1999 |
Pneumococcal septic arthritis of the shoulder. Case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Pneumococcal Infections; Rifampin; Shoulder Joint | 2002 |
Tuberculosis in blood and marrow transplant recipients.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ciprofloxacin; Female; Graft vs Host Disease; Humans; Incidence; Male; Mycobacterium tuberculosis; Rifampin; Risk Factors; Transfusion Reaction; Tuberculosis; Whole-Body Irradiation | 2002 |
[Diagnosis and antibiotic treatment of reactive arthritis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Arthritis, Reactive; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Clinical Trials as Topic; Diagnosis, Differential; DNA, Bacterial; Drug Therapy, Combination; Enteritis; Female; Humans; Male; Models, Theoretical; Polymerase Chain Reaction; Rifampin; Salmonella; Salmonella Infections; Sensitivity and Specificity; Tetracyclines; Time Factors; Urethritis; Uterine Cervicitis; Yersinia; Yersinia Infections | 2002 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Humans; Meningococcal Infections; Minocycline; Neisseria meningitidis; Randomized Controlled Trials as Topic; Rifampin | 2005 |
Clinical practice. Prevention of meningococcal disease.
Topics: Adolescent; Adult; Anti-Infective Agents; Ceftriaxone; Child; Ciprofloxacin; Disease Outbreaks; Humans; Male; Meningococcal Infections; Meningococcal Vaccines; Neisseria meningitidis; Practice Guidelines as Topic; Rifampin; United States; Vaccines, Conjugate | 2006 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Minocycline; Neisseria meningitidis; Randomized Controlled Trials as Topic; Rifampin | 2006 |
Pathological evidence of rhabdomyolysis-induced acute tubulointerstitial nephritis accompanying Legionella pneumophila pneumonia.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Humans; Kidney; Legionella pneumophila; Legionnaires' Disease; Male; Middle Aged; Nephritis, Interstitial; Rhabdomyolysis; Rifampin | 2008 |
[Could it be bacterial meningitis?].
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Community-Acquired Infections; Critical Care; Enzyme Inhibitors; Hospitalization; Humans; Meningitis, Bacterial; Neisseria meningitidis; Prognosis; Rifampin; Streptococcus pneumoniae; Tomography, X-Ray Computed | 2006 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Minocycline; Neisseria meningitidis; Randomized Controlled Trials as Topic; Rifampin | 2011 |
Antibiotics for treating human brucellosis.
Topics: Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Doxycycline; Humans; Ofloxacin; Randomized Controlled Trials as Topic; Rifampin; Streptomycin | 2012 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Minocycline; Neisseria meningitidis; Randomized Controlled Trials as Topic; Rifampin | 2013 |
Role of vancomycin in the treatment of bacteraemia and meningitis caused by Elizabethkingia meningoseptica.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Synergism; Drug Therapy, Combination; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Immunocompromised Host; Infant, Low Birth Weight; Infant, Newborn; Linezolid; Meningitis, Bacterial; Rifampin; Treatment Outcome; Vancomycin | 2017 |
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2020 |
Globally Vibrio cholera antibiotics resistance to RNA and DNA effective antibiotics: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Cephalothin; Cholera; Cholera Toxin; Ciprofloxacin; Drug Resistance, Bacterial; Furazolidone; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurantoin; Norfloxacin; Novobiocin; Rifampin; Vibrio cholerae; Virulence Factors | 2022 |
31 trial(s) available for ciprofloxacin and rifampin
Article | Year |
---|---|
Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Amikacin; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Clofazimine; Colony Count, Microbial; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin | 1992 |
Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis.
Topics: Acute Disease; Adolescent; Adult; Brucellosis; Ciprofloxacin; Doxycycline; Female; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Random Allocation; Recurrence; Rifampin | 1990 |
Multiple-dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Aging; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Male; Rifampin | 1990 |
Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Methicillin Resistance; Rifampin; Single-Blind Method; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Efficacy of ciprofloxacin in the treatment of nasopharyngeal carriers of Neisseria meningitidis.
Topics: Carrier State; Ciprofloxacin; Humans; Nasopharynx; Neisseria meningitidis; Rifampin | 1987 |
Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin.
Topics: Adolescent; Adult; Carrier State; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Female; Humans; Nasopharynx; Neisseria meningitidis; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Rural Health | 1995 |
Ciprofloxacin for rhinoscleroma and ozena.
Topics: Ciprofloxacin; Female; Humans; Male; Rhinitis, Atrophic; Rhinoscleroma; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Injections, Intravenous; Middle Aged; Neutropenia; Rifampin; Stem Cell Transplantation; Tobramycin; Vancomycin | 1994 |
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
Topics: Adult; Aged; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Female; HIV Seropositivity; HIV-1; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary | 1993 |
Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin | 1993 |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Survival Analysis; Treatment Outcome; Uveitis | 1996 |
Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Endocarditis, Bacterial; Female; Gentamicins; Humans; Infusions, Intravenous; Length of Stay; Male; Oxacillin; Penicillins; Prospective Studies; Rifampin; Staphylococcal Infections; Substance Abuse, Intravenous; Treatment Outcome; Vancomycin | 1996 |
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Female; HIV-1; Humans; Isoniazid; Male; Middle Aged; Pyrazinamide; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1996 |
Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antineoplastic Combined Chemotherapy Protocols; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Rifampin | 1997 |
Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Floxacillin; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Orthopedic Fixation Devices; Penicillins; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 1998 |
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Bacteremia; Ciprofloxacin; Clofazimine; Colony Count, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 1998 |
Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Brucellosis; Chi-Square Distribution; Ciprofloxacin; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Rifampin; Treatment Outcome | 1999 |
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Bacteremia; Canada; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Health Status; Humans; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Rifabutin; Rifampin; Treatment Outcome | 2000 |
Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antineoplastic Agents; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasms; Neutropenia; Prospective Studies; Rifampin; Statistics, Nonparametric; Treatment Outcome | 2000 |
A novel method for evaluating the antimicrobial activity of tuberculosis treatment regimens.
Topics: Antitubercular Agents; Cell Survival; Ciprofloxacin; Drug Administration Schedule; Humans; Isoniazid; Microbial Sensitivity Tests; Models, Statistical; Rifampin; Sputum; Tuberculosis, Pulmonary | 2003 |
Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.
Topics: Adjuvants, Immunologic; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Interferon-gamma; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Pilot Projects; Pyrazinamide; Radiography; Recombinant Proteins; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
A placebo-controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans.
Topics: Adult; Blood Flow Velocity; Ciprofloxacin; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Interactions; Enzyme Inhibitors; Epidemiologic Methods; Female; Humans; Infusions, Intravenous; Laser-Doppler Flowmetry; Male; Pentoxifylline; Retinal Vessels; Rifampin; Vasodilator Agents | 2006 |
Adrenocortical function in hospitalised patients with active pulmonary tuberculosis receiving a rifampicin-based regimen -- a pilot study.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Aldosterone; Antibiotics, Antitubercular; Biomarkers; Ciprofloxacin; Dehydroepiandrosterone Sulfate; Female; Follow-Up Studies; Humans; Hydrocortisone; Immunoassay; Inpatients; Male; Pilot Projects; Prospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 2006 |
The effects of some antibiotics on polymorphonuclear leukocyte functions of elderly patients in vitro before and after zinc supplementation.
Topics: Adult; Aged; Aged, 80 and over; Aging; Anti-Bacterial Agents; Candida albicans; Cefotaxime; Ciprofloxacin; Doxycycline; Humans; Neutrophils; Phagocytosis; Rifampin; Zinc | 2006 |
Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647].
Topics: Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Humans; Rifampin; Spine; Spondylitis; Streptomycin | 2006 |
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Immunotherapy; Male; Middle Aged; Opportunistic Infections; Rifampin; Tuberculosis, Pulmonary | 2008 |
Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
Topics: Aged; Anti-Bacterial Agents; Blood Sedimentation; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Area Under Curve; Blood Glucose; Ciprofloxacin; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Female; Glyburide; Humans; Hypoglycemic Agents; Infusions, Intravenous; Liver; Liver-Specific Organic Anion Transporter 1; Male; Metabolic Clearance Rate; Rifampin | 2009 |
A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis.
Topics: Adult; Anti-Infective Agents; Brucellosis; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Humans; Male; Prospective Studies; Recurrence; Rifampin | 2009 |
Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intramuscular; Isoniazid; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Young Adult | 2011 |
Ciprofloxacin and rifampin have opposite effects on levothyroxine absorption.
Topics: Absorption; Administration, Oral; Adolescent; Adult; Area Under Curve; Ciprofloxacin; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Humans; Hypothyroidism; Intestinal Absorption; Liver; Male; Prospective Studies; Rifampin; Thyroid Hormones; Thyroxine; Time Factors; Young Adult | 2013 |
482 other study(ies) available for ciprofloxacin and rifampin
Article | Year |
---|---|
Antibacterial diterpenes from Calceolaria pinifolia.
Topics: Animals; Anti-Bacterial Agents; Argentina; Bacillus subtilis; Diterpenes; Erythrocytes; Escherichia coli; Female; Humans; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Plants, Medicinal; Scrophulariaceae; Staphylococcus aureus | 2003 |
Antituberculous activity of some aryl semicarbazone derivatives.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Mycobacterium tuberculosis; Semicarbazones; Structure-Activity Relationship | 2004 |
Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases.
Topics: Alkaloids; Animals; Anti-HIV Agents; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Carbolines; Indonesia; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Porifera | 2004 |
Identification of heteroarylenamines as a new class of antituberculosis lead molecules.
Topics: Amines; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance; Inhibitory Concentration 50; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens.
Topics: Annonaceae; Anti-Bacterial Agents; Gabon; Glycosides; Methicillin Resistance; Molecular Structure; Plant Leaves; Plants, Medicinal; Staphylococcus aureus | 2006 |
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.
Topics: Alzheimer Disease; Animals; Female; Glycogen Synthase Kinase 3; HIV-1; Humans; Indole Alkaloids; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oryzias; Plasmodium falciparum; Porifera; Structure-Activity Relationship | 2006 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.
Topics: Anti-Bacterial Agents; Benzimidazoles; DNA Topoisomerase IV; Drug Design; Escherichia coli; Microbial Sensitivity Tests; Mutation; Staphylococcus aureus; Streptococcus pneumoniae; Structure-Activity Relationship; Topoisomerase II Inhibitors; Urea | 2007 |
Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Hospitals, University; Humans; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids | 2007 |
Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
N-thiolated beta-lactams: Studies on the mode of action and identification of a primary cellular target in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Coenzyme A; Disulfides; Microbial Sensitivity Tests; Oxidation-Reduction; Staphylococcus aureus; Structure-Activity Relationship; Sulfhydryl Compounds; Thiosulfonic Acids | 2007 |
In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Infective Agents; Carbapenems; Drug Combinations; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2007 |
Antibacterial nicotinamide adenine dinucleotide synthetase inhibitors: amide- and ether-linked tethered dimers with alpha-amino acid end groups.
Topics: Amide Synthases; Amides; Amino Acids; Anti-Bacterial Agents; Bacillus subtilis; Detergents; Dimerization; Ethers; Gram-Positive Bacteria; Microbial Sensitivity Tests; NAD; Octoxynol; Structure-Activity Relationship | 2007 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm.
Topics: Amidines; Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; DNA-Directed RNA Polymerases; Enzyme Inhibitors; Hydroxylamines; Luminescence; Rifampin; Staphylococcus epidermidis; Structure-Activity Relationship; Transcription, Genetic | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.
Topics: Antifungal Agents; Antineoplastic Agents; Antiparasitic Agents; Cell Line, Tumor; Depsipeptides; Drug Screening Assays, Antitumor; Fusarium; Humans; Lysosomes; Microbiological Techniques; Mycobacterium tuberculosis; Opportunistic Infections; Parasitic Sensitivity Tests; Receptor, ErbB-3; Structure-Activity Relationship | 2007 |
Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Drug Resistance; Flow Cytometry; Green Fluorescent Proteins; Plasmodium falciparum; Protein Synthesis Inhibitors; Topoisomerase II Inhibitors | 2007 |
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cells, Cultured; Colon; Crohn Disease; Culture Media; Escherichia coli; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Monocytes; Mucous Membrane | 2008 |
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitro.
Topics: Animals; Azathioprine; Bacteriological Techniques; Cattle; Cattle Diseases; Colony Count, Microbial; Crohn Disease; Culture Media; Humans; Immunosuppressive Agents; Mercaptopurine; Microbial Sensitivity Tests; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Reagent Kits, Diagnostic | 2008 |
Evaluation of a 2-pyridone, KRQ-10018, against Mycobacterium tuberculosis in vitro and in vivo.
Topics: Animals; Antitubercular Agents; Biological Availability; Interferon-gamma; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridones; Quinolones; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Phenotype; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Thymidine | 2008 |
Delayed development of linezolid resistance in Staphylococcus aureus following exposure to low levels of antimicrobial agents.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fusidic Acid; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Recombination, Genetic; Rifampin; RNA, Ribosomal, 23S; Staphylococcus aureus; Time Factors | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA Topoisomerase IV; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Mutation; Quinolones; Rifamycins; RNA, Bacterial; Staphylococcus aureus; Topoisomerase II Inhibitors | 2008 |
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2008 |
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
Topics: Administration, Inhalation; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Disease Models, Animal; Glycopeptides; Humans; Lipoglycopeptides; Mice; Microbial Sensitivity Tests; Spores, Bacterial; Treatment Outcome | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms.
Topics: Anti-Infective Agents; Biofilms; Bioreactors; Electricity; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 2009 |
Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Genes, Bacterial; Humans | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
Topics: Bacterial Proteins; China; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals, Teaching; Humans; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcal Infections | 2009 |
Theileria apicoplast as a target for chemotherapy.
Topics: Animals; Antiprotozoal Agents; Cattle; Drug Delivery Systems; Inhibitory Concentration 50; Models, Biological; Plastids; Theileria; Theileriasis | 2009 |
5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species.
Topics: Antitubercular Agents; Combinatorial Chemistry Techniques; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrofurans; Structure-Activity Relationship; Thiosemicarbazones; Tuberculosis | 2009 |
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
Topics: Africa; Genotype; Humans; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Phenotype; Sequence Analysis, DNA; Time Factors | 2009 |
Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua.
Topics: Anti-Bacterial Agents; Bacillus anthracis; Cyanobacteria; Indole Alkaloids; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Synthesis, spectral and biological evaluation of some new thiazolidinones and thiazoles based on t-3-alkyl-r-2,c-6-diarylpiperidin-4-ones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Fungi; Microbial Sensitivity Tests; Structure-Activity Relationship; Thiazoles; Thiazolidines | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains.
Topics: Animals; Anti-Bacterial Agents; Bacillus anthracis; Cell Death; Cell Line; Gram-Negative Bacteria; Gram-Positive Bacteria; Macrophages; Mice; Staphylococcus aureus; Yersinia pestis | 2009 |
Design, synthesis, and structure-activity relationships of benzophenone-based tetraamides as novel antibacterial agents.
Topics: Amides; Animals; Anti-Bacterial Agents; Benzophenones; Cell Membrane; Cell Wall; CHO Cells; Cricetinae; Cricetulus; DNA, Bacterial; Drug Design; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Protein Biosynthesis; RNA, Bacterial; Staphylococcus aureus; Structure-Activity Relationship | 2009 |
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2009 |
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries | 2009 |
1,3-Dipolar cycloaddition of C-aryl-N-phenylnitrones to (R)-1-(1-phenylethyl)-3-[(E)-arylmethylidene]tetrahydro-4(1H)-pyridinones: synthesis and antimycobacterial evaluation of enantiomerically pure spiroisoxazolidines.
Topics: Anti-Bacterial Agents; Drug Discovery; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Nitrogen Oxides; Oxazoles; Pyridones; Stereoisomerism | 2010 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.
Topics: Animals; Anti-Infective Agents; Carbazoles; Cerebellar Diseases; Indole Alkaloids; Mice; Microbial Sensitivity Tests; Molecular Structure; Neurogenic Inflammation; Porifera; Stereoisomerism; Structure-Activity Relationship | 2010 |
New 1,3-oxazolo[4,5-c]quinoline derivatives: synthesis and evaluation of antibacterial and antituberculosis properties.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Crystallography, X-Ray; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Oxazoles; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Anti-infective discorhabdins from a deep-water alaskan sponge of the genus Latrunculia.
Topics: Alkaloids; Animals; Anti-Infective Agents; Antimalarials; Antiprotozoal Agents; Hepacivirus; Heterocyclic Compounds, 4 or More Rings; Mice; Microbial Sensitivity Tests; Molecular Structure; Oceans and Seas; Plasmodium berghei; Plasmodium falciparum; Porifera; Quinones; Spiro Compounds | 2010 |
New quinoline derivatives: synthesis and investigation of antibacterial and antituberculosis properties.
Topics: Antitubercular Agents; Bacteria; Crystallography, X-Ray; Microbial Sensitivity Tests; Quinolines | 2010 |
Different classes of antibiotics differentially influence shiga toxin production.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriophages; Ciprofloxacin; Escherichia coli; Escherichia coli O157; Shiga Toxin; Sulfamethoxazole; Trimethoprim | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
Anti-tubercular agents. Part 5: synthesis and biological evaluation of benzothiadiazine 1,1-dioxide based congeners.
Topics: Animals; Antitubercular Agents; Bacteria; Benzothiadiazines; Cell Line; Cell Survival; Female; Fungi; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2010 |
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cytotoxins; Methicillin-Resistant Staphylococcus aureus; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Virulence | 2010 |
Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.
Topics: Chromosomes, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Polymerase Chain Reaction | 2010 |
Design, synthesis and in vitro evaluation of antitubercular and antimicrobial activity of some novel pyranopyrimidines.
Topics: Anti-Infective Agents; Aspergillus niger; Bacteria; Drug Design; Drug Evaluation, Preclinical; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Pyrimidines | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A regio- and stereoselective 1,3-dipolar cycloaddition for the synthesis of novel spiro-pyrrolothiazolyloxindoles and their antitubercular evaluation.
Topics: Antitubercular Agents; Cyclization; Indoles; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Oxindoles; Spiro Compounds; Stereoisomerism | 2010 |
A facile 1,3-dipolar cycloaddition of azomethine ylides to 2-arylidene-1,3-indanediones: synthesis of dispiro-oxindolylpyrrolothiazoles and their antimycobacterial evaluation.
Topics: Antitubercular Agents; Azo Compounds; Crystallography, X-Ray; Indans; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Spiro Compounds; Stereoisomerism; Thiazoles; Thiosemicarbazones | 2010 |
Synthesis and anti-mycobacterial activities of triazoloquinolones.
Topics: Anti-Bacterial Agents; Candida; Cell Line, Tumor; Humans; Microbial Sensitivity Tests; Mycobacterium; Quinolones | 2011 |
Synthesis and in vitro antimycobacterial activity of 8-OCH(3) ciprofloxacin methylene and ethylene isatin derivatives.
Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Ciprofloxacin; Isatin; Microbial Sensitivity Tests; Mycobacterium; Oximes; Semicarbazones; Vero Cells | 2011 |
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
Topics: Antitubercular Agents; Carbohydrates; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Thiocarbamates; Thioglucosides | 2011 |
New quinolin-4-yl-1,2,3-triazoles carrying amides, sulphonamides and amidopiperazines as potential antitubercular agents.
Topics: Amides; Antitubercular Agents; Crystallography, X-Ray; Dose-Response Relationship, Drug; Escherichia coli; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Piperazines; Pseudomonas; Quinolines; Stereoisomerism; Streptococcus; Structure-Activity Relationship; Triazoles | 2011 |
A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrimidines; Thiones | 2011 |
Antimycobacterial activity of novel 1,2,4-oxadiazole-pyranopyridine/chromene hybrids generated by chemoselective 1,3-dipolar cycloadditions of nitrile oxides.
Topics: Antibiotics, Antitubercular; Benzopyrans; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Nitriles; Oxadiazoles; Oxides; Pyridines; Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A facile four-component sequential protocol in the expedient synthesis of novel 2-aryl-5-methyl-2,3-dihydro-1H-3-pyrazolones in water and their antitubercular evaluation.
Topics: Antitubercular Agents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Pyrazolones; Water | 2011 |
Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies.
Topics: Animals; Antitubercular Agents; Humans; Mice; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; NIH 3T3 Cells; Quinolines; Structure-Activity Relationship; Thiadiazoles; Tuberculosis | 2011 |
Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Catalytic Domain; Drug Design; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Humans; Models, Molecular; Mycobacterium tuberculosis; Oxazolidinones; Protein Binding; Quinolines; Tuberculosis | 2011 |
Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents.
Topics: Antitubercular Agents; Bacteria; Drug Design; Hydrazines; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Quinolines | 2011 |
Synthesis and biological evaluation of novel pyrazole derivatives with anticancer activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Chemistry Techniques, Synthetic; Cyclin-Dependent Kinase Inhibitor p21; Drug Evaluation, Preclinical; Humans; Indoles; Mice; Microtubules; Models, Molecular; Protein Multimerization; Protein Structure, Quaternary; Pyrazoles; Tubulin; Tumor Suppressor Protein p53 | 2011 |
A facile synthesis of carbocycle-fused mono and bis-1,2,3-selenadiazoles and their antimicrobial and antimycobacterial studies.
Topics: Anti-Bacterial Agents; Azoles; Candida albicans; Chemistry Techniques, Synthetic; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2011 |
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
Topics: Antifungal Agents; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Fungi; Indoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2011 |
Camphorsulfonic acid catalysed facile tandem double Friedlander annulation protocol for the synthesis of phenoxy linked bisquinoline derivatives and discovery of antitubercular agents.
Topics: Animals; Antitubercular Agents; Camphor; Catalysis; Chemistry Techniques, Synthetic; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Phenols; Quinolines; Structure-Activity Relationship | 2012 |
Design, synthesis of some new (2-aminothiazol-4-yl)methylester derivatives as possible antimicrobial and antitubercular agents.
Topics: Anti-Infective Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Crystallography, X-Ray; Fungi; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Mycoses; Thiazoles; Tuberculosis | 2012 |
Anti-mycobacterial activities of some cationic and anionic calix[4]arene derivatives.
Topics: 2,2'-Dipyridyl; Anions; Antitubercular Agents; Calixarenes; Guanidine; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenols; Quaternary Ammonium Compounds; Tuberculosis | 2012 |
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
Topics: Alpinia; Antibiotics, Antitubercular; Antitubercular Agents; Diarylheptanoids; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Plant Extracts; Seeds | 2012 |
Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents.
Topics: Antifungal Agents; Antitubercular Agents; Bacteria; Benzothiazoles; Chemistry Techniques, Synthetic; Fungi; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2012 |
A solvent free, four-component synthesis and 1,3-dipolar cycloaddition of 4(H)-pyrans with nitrile oxides: synthesis and discovery of antimycobacterial activity of enantiomerically pure 1,2,4-oxadiazoles.
Topics: Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Drug Discovery; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitriles; Oxadiazoles; Oxides; Piperidines; Pyrans; Stereoisomerism | 2012 |
New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation.
Topics: Antimalarials; Antitubercular Agents; Chemistry Techniques, Synthetic; Electrons; Fungi; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines | 2012 |
Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
Topics: Anti-Infective Agents; Antitubercular Agents; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazoles; Structure-Activity Relationship | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synthesis and identification of β-aryloxyquinoline based diversely fluorine substituted N-aryl quinolone derivatives as a new class of antimicrobial, antituberculosis and antioxidant agents.
Topics: Animals; Anti-Infective Agents; Antioxidants; Antitubercular Agents; Artemia; Aspergillus fumigatus; Candida albicans; Dose-Response Relationship, Drug; Fluorine; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Mycobacterium tuberculosis; Ovum; Quinolines; Structure-Activity Relationship | 2013 |
Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Artemia; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Motor Activity; Quinolones; Structure-Activity Relationship; Tuberculosis | 2013 |
Design and synthesis of positional isomers of 5 and 6-bromo-1-[(phenyl)sulfonyl]-2-[(4-nitrophenoxy)methyl]-1H-benzimidazoles as possible antimicrobial and antitubercular agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus flavus; Benzimidazoles; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Klebsiella pneumoniae; Models, Molecular; Molecular Structure; Mycobacterium; Rhizopus; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Synthesis and evaluation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl)acetyl)piperazin-1-yl)quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents.
Topics: Anti-Bacterial Agents; Carboxylic Acids; Escherichia coli; Escherichia coli Infections; Halogenation; Humans; Mycobacterium tuberculosis; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Tuberculosis | 2014 |
Synthesis and characterization of new N-(4-(4-chloro-1H-imidazol-1-yl)-3-methoxyphenyl)amide/sulfonamide derivatives as possible antimicrobial and antitubercular agents.
Topics: Amides; Anti-Infective Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Imidazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Structure-Activity Relationship; Sulfonamides | 2014 |
Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Hydrazones; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles | 2014 |
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship | 2014 |
Mahorones, highly brominated cyclopentenones from the red alga Asparagopsis taxiformis.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Antifungal Agents; Cyclopentanes; Humans; Hydrocarbons, Brominated; Indian Ocean; Molecular Structure; Rhodophyta | 2014 |
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
Topics: Acute Disease; Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Biological Availability; Chronic Disease; DNA Gyrase; Drug Resistance, Bacterial; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Humans; Macrophages; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Piperidines; Protein Subunits; Rats; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tuberculosis, Pulmonary | 2014 |
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2014 |
Design, synthesis and anti-mycobacterial activity of 1,2,3,5-tetrasubstituted pyrrolyl-N-acetic acid derivatives.
Topics: Acetates; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrroles; Structure-Activity Relationship | 2014 |
Benzimidazoles: novel mycobacterial gyrase inhibitors from scaffold morphing.
Topics: | 2014 |
Synthesis, antimycobacterial and antibacterial evaluation of l-[(1R, 2S)-2-fluorocyclopropyl]fluoroquinolone derivatives containing an oxime functional moiety.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Structure; Oximes; Structure-Activity Relationship | 2014 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Syntheses and Antituberculosis Activity of 1,3-Benzothiazinone Sulfoxide and Sulfone Derived from BTZ043.
Topics: | 2015 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Syntheses and evaluation of substituted aromatic hydroxamates and hydroxamic acids that target Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Hydrocarbons, Aromatic; Hydroxamic Acids; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2015 |
Left-Hand Side Exploration of Novel Bacterial Topoisomerase Inhibitors to Improve Selectivity against hERG Binding.
Topics: | 2015 |
Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Spiro Compounds; Structure-Activity Relationship; Thiazoles | 2015 |
Re-engineering nalidixic acid's chemical scaffold: A step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nalidixic Acid; Proteus vulgaris; Structure-Activity Relationship | 2015 |
Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enterococcus; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrrolidines; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant | 2015 |
Synthesis, antimycobacterial and antibacterial activity of l-[(1R,2S)-2-fluorocyclopropyl]naphthyridone derivatives containing an oxime-functionalized pyrrolidine moiety.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Levofloxacin; Moxifloxacin; Naphthyridines; Oximes; Pyrrolidines; Stereoisomerism | 2015 |
Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Escherichia coli; Humans; Isoxazoles; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Pyrroles; Staphylococcus aureus; Thiourea | 2016 |
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Piperazines; Pyridines; Structure-Activity Relationship; Thiazines; Tuberculosis | 2016 |
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
Topics: Biofilms; Carbon-13 Magnetic Resonance Spectroscopy; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Halogens; HeLa Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenazines; Proton Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 2016 |
Synthesis, antimycobacterial and antibacterial activity of 1-(6-amino-3,5-difluoropyridin-2-yl)fluoroquinolone derivatives containing an oxime functional moiety.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Fluoroquinolones; Oximes | 2016 |
Benzo[d]thiazol-2-yl(piperazin-1-yl)methanones as new anti-mycobacterial chemotypes: Design, synthesis, biological evaluation and 3D-QSAR studies.
Topics: Animals; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Piperazine; Piperazines; Quantitative Structure-Activity Relationship; RAW 264.7 Cells | 2016 |
Metabolites from the Fungal Endophyte Aspergillus austroafricanus in Axenic Culture and in Fungal-Bacterial Mixed Cultures.
Topics: Animals; Anti-Bacterial Agents; Aspergillus; Bacillus subtilis; Mice; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Sesquiterpenes; Staphylococcus aureus; Xanthones | 2016 |
Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
Topics: Antitubercular Agents; Cell Survival; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Structure-Activity Relationship | 2016 |
Synthesis of novel triazole/isoxazole functionalized 7-(trifluoromethyl)pyrido[2,3-d]pyrimidine derivatives as promising anticancer and antibacterial agents.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Isoxazoles; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2016 |
Biological characterization of the hygrobafilomycin antibiotic JBIR-100 and bioinformatic insights into the hygrolide family of natural products.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Biological Products; Computational Biology; Dose-Response Relationship, Drug; Fungi; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2016 |
Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Rifamycins; Staphylococcus aureus; Structure-Activity Relationship | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Cell Line, Tumor; Chemistry Techniques, Synthetic; Computer Simulation; Drug Design; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Conformation; Pyrroles | 2017 |
Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents.
Topics: Antitubercular Agents; Catechols; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2017 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.
Topics: Anti-Bacterial Agents; Antimalarials; Antitubercular Agents; Clostridium tetani; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Thiazines | 2017 |
A robust synthesis of functionalized 2H-indazoles via solid state melt reaction (SSMR) and their anti-tubercular activity.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Indazoles; Isoniazid; Mycobacterium tuberculosis; Rifampin; Structure-Activity Relationship | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Lipophosphonoxins II: Design, Synthesis, and Properties of Novel Broad Spectrum Antibacterial Agents.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lipid Bilayers; Male; Mice, Inbred ICR; Microbial Sensitivity Tests; Phospholipids; Pyrazoles; Rabbits; Skin Irritancy Tests; Stereoisomerism; Structure-Activity Relationship; Uridine Monophosphate | 2017 |
Cyclic Cystine-Bridged Peptides from the Marine Sponge Clathria basilana Induce Apoptosis in Tumor Cells and Depolarize the Bacterial Cytoplasmic Membrane.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Enterococcus faecium; Indonesia; Marine Biology; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Porifera; Staphylococcus aureus | 2017 |
Primaquine hybrids as promising antimycobacterial and antimalarial agents.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Plasmodium berghei; Primaquine; Rats; Structure-Activity Relationship | 2018 |
Synthesis and antimycobacterial activity of 1-(β-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole.
Topics: Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles | 2018 |
Chloramphenicol Derivatives with Antibacterial Activity Identified by Functional Metagenomics.
Topics: Anti-Bacterial Agents; Chloramphenicol; Escherichia coli; Escherichia coli Proteins; Metagenomics; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests | 2018 |
Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship.
Topics: Animals; Antitubercular Agents; Carbanilides; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; RAW 264.7 Cells; Structure-Activity Relationship; Thiazoles | 2018 |
A novel synthesis of 2-arylbenzimidazoles in molecular sieves-MeOH system and their antitubercular activity.
Topics: Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Binding Sites; Body Weight; DNA Gyrase; Imidazoles; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Structure, Tertiary; Structure-Activity Relationship | 2018 |
Design, synthesis, molecular-docking and antimycobacterial evaluation of some novel 1,2,3-triazolyl xanthenones.
Topics: | 2017 |
Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with a 4-phenylthiazol-2-amine scaffold.
Topics: | 2018 |
Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Quinolines; Structure-Activity Relationship | 2019 |
Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Pyrimidines; Pyrroles; Structure-Activity Relationship; Triazoles | 2019 |
Synthesis of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines as potent inhibitors of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Morpholines; Mycobacterium tuberculosis; Piperazine; Quinolines; Structure-Activity Relationship | 2019 |
Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents.
Topics: Antitubercular Agents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinolines; Triazoles | 2019 |
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests; Molecular Structure; Quinolinium Compounds; Structure-Activity Relationship | 2019 |
Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indoles; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2019 |
Design, synthesis and biological evaluation of antimicrobial diarylimine and -amine compounds targeting the interaction between the bacterial NusB and NusE proteins.
Topics: Aniline Compounds; Anti-Bacterial Agents; Bacterial Proteins; Benzylamines; Caco-2 Cells; Drug Design; Erythrocytes; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Hemolysis; Humans; Keratinocytes; Microbial Sensitivity Tests; Molecular Structure; Protein Binding; Schiff Bases; Structure-Activity Relationship; Transcription Factors | 2019 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation.
Topics: Antitubercular Agents; Antiviral Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Orthomyxoviridae; Structure-Activity Relationship | 2019 |
Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent against Gram-Negative Bacteria.
Topics: Anti-Bacterial Agents; Dimerization; Gram-Negative Bacteria; Novobiocin; Tobramycin | 2019 |
Development of (4-methoxyphenyl)-1H-tetrazol-5-amine regioisomers as a new class of selective antitubercular agents.
Topics: Amines; Antitubercular Agents; Cell Death; Cell Line; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Structure-Activity Relationship; Tetrazoles | 2020 |
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacillus subtilis; Benzofurans; Lichens; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Triazoles | 2020 |
Novel benzimidazole-acrylonitrile hybrids and their derivatives: Design, synthesis and antimycobacterial activity.
Topics: Acrylonitrile; Anti-Bacterial Agents; Benzimidazoles; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2020 |
Biological evaluation and chemoproteomics reveal potential antibacterial targets of a cajaninstilbene-acid analogue.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Proteomics; Salicylates; Stilbenes; Structure-Activity Relationship | 2020 |
Design, synthesis and biological evaluation of novel hybrids of N-aryl pyrrothine-base α-pyrone as bacterial RNA polymerase inhibitors.
Topics: Anti-Bacterial Agents; Binding Sites; Candida albicans; Cell Survival; DNA-Directed RNA Polymerases; Drug Design; Enzyme Inhibitors; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Pyrones; Structure-Activity Relationship | 2020 |
Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Staphylococcal Infections; Structure-Activity Relationship; Thiazoles | 2020 |
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
Topics: Animals; Antifungal Agents; Antitubercular Agents; Aspergillus niger; Bacterial Proteins; Drug Design; Gram-Negative Bacteria; Isoniazid; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Protein Binding; RAW 264.7 Cells; Triazoles | 2020 |
Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles.
Topics: Amination; Antitubercular Agents; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Schiff Bases; Thiazoles; Tuberculosis | 2020 |
Semisynthetic Analogs of the Antibiotic Fidaxomicin-Design, Synthesis, and Biological Evaluation.
Topics: | 2020 |
Discovery of novel N
Topics: A549 Cells; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cytidine; Drug Discovery; Fungi; Humans; Microbial Sensitivity Tests | 2021 |
4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents.
Topics: Aniline Compounds; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacteria; Humans; Liver; Microbial Sensitivity Tests; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Synthetic cajaninstilbene acid derivatives eradicate methicillin-resistant Staphylococcus aureus persisters and biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Survival; Cell Wall; Disease Models, Animal; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Salicylates; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Stilbenes; Structure-Activity Relationship | 2021 |
Modification of 5-methylphenanthridium from benzothiazoles to indoles as potent FtsZ inhibitors: Broadening the antibacterial spectrum toward vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzothiazoles; Cytoskeletal Proteins; Humans; Indoles; Molecular Structure; Phenanthridines; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Design, synthesis, and antibacterial activity of
Topics: | 2021 |
Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells | 2022 |
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests | 2022 |
Design and synthesis of quinolinium-based derivatives targeting FtsZ for antibacterial evaluation and mechanistic study.
Topics: Amines; Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Staphylococcus aureus; Staphylococcus epidermidis; Structure-Activity Relationship | 2022 |
Design and evaluation of poly-nitrogenous adjuvants capable of potentiating antibiotics in Gram-negative bacteria.
Topics: | 2022 |
In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes.
Topics: Anti-Bacterial Agents; Azithromycin; Chemotaxis, Leukocyte; Ciprofloxacin; Drug Delivery Systems; Erythromycin; Growth Inhibitors; Humans; Microbial Sensitivity Tests; Neutrophils; Rifampin; Streptococcus pyogenes | 1992 |
In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Erythromycin; Humans; In Vitro Techniques; Legionella; Microbial Sensitivity Tests; Respiratory Tract Infections; Rifampin; Virginiamycin | 1992 |
In vitro activity of fosfomycin against 'problem' gram-positive cocci.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Positive Cocci; Microbial Sensitivity Tests; Rifampin | 1992 |
Cat-scratch disease diagnosis and treatment.
Topics: Cat-Scratch Disease; Ciprofloxacin; Humans; Rifampin | 1992 |
Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin.
Topics: Administration, Oral; Animals; Brucellosis; Ciprofloxacin; Doxycycline; Injections, Intraperitoneal; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Pulmonary abscess due to a rifampin and fluoroquinolone resistant Rhodococcus equi strain in a HIV infected patient.
Topics: Actinomycetales Infections; Adult; Ciprofloxacin; Drug Resistance, Microbial; HIV Infections; Humans; Lung Abscess; Male; Rhodococcus equi; Rifampin | 1992 |
Combined ciprofloxacin/rifampicin therapy in methicillin-resistant Staphylococcus aureus (MRSA) infection.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Drug Therapy, Combination; Humans; Methicillin Resistance; Middle Aged; Prospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 1992 |
Ciprofloxacin in patients with mycobacterial infections: experience in 15 patients.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Rifabutin; Rifampin; Rifamycins; Tuberculosis, Pulmonary | 1991 |
Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16.
Topics: Anti-Infective Agents; Bacterial Proteins; Chloramphenicol; Ciprofloxacin; Escherichia coli; Fleroxacin; Pefloxacin; Rifampin; RNA, Bacterial | 1990 |
Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase.
Topics: Cell Membrane Permeability; Chloramphenicol Resistance; Ciprofloxacin; DNA Topoisomerases, Type II; Escherichia coli; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Rifampin; RNA, Bacterial | 1991 |
Chemoprophylaxis of meningitis.
Topics: Ciprofloxacin; Humans; Meningitis, Haemophilus; Meningitis, Meningococcal; Rifampin; Vaccination | 1991 |
Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing.
Topics: Abscess; Animals; Cefazolin; Ciprofloxacin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Neutrophils; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus | 1991 |
Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers.
Topics: Aged; Ciprofloxacin; Clindamycin; Drug Interactions; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Male; Rifampin; Serum Bactericidal Test | 1991 |
Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Diffusion Chambers, Culture; Disease Models, Animal; Drug Resistance, Microbial; Fleroxacin; Foreign Bodies; Gentamicins; Kinetics; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1991 |
Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis.
Topics: Adult; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Humans; Male; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 1991 |
Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Rifampin | 1991 |
A problem with oral rifampicin in the prophylaxis of meningococcal infection.
Topics: Administration, Oral; Ciprofloxacin; Humans; Infant; Male; Meningococcal Infections; Penicillins; Rifampin; Vomiting | 1991 |
In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Ciprofloxacin; Drug Synergism; Ethambutol; Fluoroquinolones; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 1990 |
Levels of rifampin and ciprofloxacin in nasal secretions: correlation with MIC90 and eradication of nasopharyngeal carriage of bacteria.
Topics: Carrier State; Chromatography, High Pressure Liquid; Ciprofloxacin; Haemophilus influenzae; Humans; Methicillin Resistance; Nasal Mucosa; Nasopharynx; Neisseria meningitidis; Rifampin; Saliva; Staphylococcus aureus; Tissue Distribution | 1990 |
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Fleroxacin; Foreign-Body Reaction; Male; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1990 |
Treatment failure with teicoplanin and response to oral antibiotic regimens.
Topics: Administration, Oral; Adult; Ciprofloxacin; Endocarditis, Bacterial; Female; Glycopeptides; Humans; Male; Rifampin; Staphylococcal Infections; Teicoplanin | 1990 |
Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Ciprofloxacin; Drug Resistance, Microbial; Fusidic Acid; Gentamicins; Glycopeptides; Gram-Positive Bacteria; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Staphylococcus; Staphylococcus aureus; Teicoplanin | 1990 |
The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Legionella; Microbial Sensitivity Tests; Mutation; Rifampin; Time Factors | 1990 |
Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Amikacin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Female; Humans; Infusions, Intravenous; Male; Mycobacterium avium-intracellulare Infection; Rifampin; Vomiting | 1990 |
Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.
Topics: Animals; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Male; Methicillin; Osteomyelitis; Pefloxacin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin | 1990 |
DNA breakdown by the 4-quinolones and its significance.
Topics: Ciprofloxacin; DNA, Bacterial; Escherichia coli; Nalidixic Acid; Norfloxacin; Rifampin; SOS Response, Genetics; Species Specificity; Time Factors | 1990 |
Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Sedimentation; Ciprofloxacin; Diabetes Complications; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Otitis Externa; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Rifampin | 1989 |
[Multi-step increase in resistance of Neisseria gonorrhoeae isolates after repeated in-vitro subinhibitory concentrations of second-generation quinolones].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; In Vitro Techniques; Neisseria gonorrhoeae; Penicillin G; Rifampin | 1989 |
Susceptibility of Legionella pneumophila to eight antimicrobial agents including four macrolides under different assay conditions.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Enoxacin; Erythromycin; Imipenem; Legionella; Leucomycins; Microbial Sensitivity Tests; Rifampin | 1989 |
Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anaphylaxis; Ciprofloxacin; Humans; Male; Rifampin; Tuberculosis | 1989 |
Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin.
Topics: Adult; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacterial; Female; Follow-Up Studies; Humans; Male; Pilot Projects; Rifampin; Staphylococcal Infections; Substance Abuse, Intravenous | 1989 |
Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
Topics: Ciprofloxacin; Drug Interactions; Humans; Kinetics; Microbial Sensitivity Tests; Oxacillin; Regression Analysis; Rifampin; Serum Bactericidal Test; Staphylococcus aureus | 1989 |
Combination chemotherapy with ciprofloxacin for infection with Mycobacterium tuberculosis in mouse models.
Topics: Animals; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Isoniazid; Male; Mice; Rifampin; Tuberculosis | 1989 |
Comparison of in vivo and in vitro activities of antibiotics with different modes of action against a tolerant and a non-tolerant Staphylococcus aureus strain.
Topics: Agranulocytosis; Animals; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Mice; Penicillin G; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 1989 |
Enhanced elimination of ciprofloxacin after multiple-dose administration of rifampin to rabbits.
Topics: Animals; Ciprofloxacin; Drug Interactions; Half-Life; Injections, Intramuscular; Male; Microbial Sensitivity Tests; Rabbits; Rifampin | 1989 |
In-vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus.
Topics: Ciprofloxacin; Drug Interactions; Fusidic Acid; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus; Time Factors | 1989 |
Ciprofloxacin, imipenem and rifampicin: in-vitro synergy of two and three drug combinations against Pseudomonas cepacia.
Topics: Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas; Rifampin; Sputum | 1989 |
Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis.
Topics: Animals; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Kidney; Male; Rabbits; Rifampin; Spleen; Staphylococcal Infections | 1989 |
Pathogenesis and chemotherapy of experimental Legionella pneumophila infection in the chick embryo.
Topics: Animals; Chick Embryo; Ciprofloxacin; Colony Count, Microbial; Doxycycline; Erythromycin; Heart; Kidney; Legionella; Legionnaires' Disease; Liver; Myocardium; Rifampin; Spleen | 1989 |
Electron microscopy of the pathology and chemotherapy of Legionella pneumophila infection in the chick embryo.
Topics: Animals; Anti-Bacterial Agents; Chick Embryo; Ciprofloxacin; Doxycycline; Erythromycin; Legionella; Legionnaires' Disease; Microscopy, Electron; Rifampin | 1989 |
Treatment of experimental Legionnaires' disease by aerosol administration of rifampicin, ciprofloxacin, and erythromycin.
Topics: Aerosols; Animals; Anti-Bacterial Agents; Ciprofloxacin; Erythromycin; Guinea Pigs; Legionella; Legionnaires' Disease; Lung; Quinolines; Rifampin | 1986 |
Chemotherapy of experimental (murine) Clostridium perfringens type A gas gangrene.
Topics: Animals; Ciprofloxacin; Clindamycin; Clostridium perfringens; Disease Models, Animal; Gas Gangrene; Imipenem; Mice; Microbial Sensitivity Tests; Penicillin G; Rifampin | 1988 |
In vitro activity of the new quinoline derivative ciprofloxacin alone and in combination against various Mycobacterium-, Salmonella- and Escherichia coli strains.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Interactions; Escherichia coli; Humans; Kinetics; Microbial Sensitivity Tests; Mycobacterium; Quinolines; Rifampin; Salmonella | 1986 |
In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis.
Topics: Aminocoumarins; Anti-Bacterial Agents; Ciprofloxacin; Coumarins; Drug Combinations; Microbial Sensitivity Tests; Quinolines; Rifabutin; Rifampin; Rifamycins; Staphylococcus aureus; Staphylococcus epidermidis | 1986 |
Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
Topics: Aminocoumarins; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Coumarins; DNA-Directed RNA Polymerases; Drug Interactions; Glycopeptides; Humans; Rifabutin; Rifampin; Rifamycins; Staphylococcus aureus; Teicoplanin; Topoisomerase II Inhibitors; Vancomycin | 1987 |
Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
Topics: Ciprofloxacin; Drug Synergism; Enterobacter; Enterobacteriaceae; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin; Serratia marcescens; Thienamycins | 1987 |
Effect of Ro 23-6240 on sensitive and resistant intracellular mycobacteria.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Fleroxacin; Humans; Macrophages; Mice; Mycobacterium; Nontuberculous Mycobacteria; Rifampin | 1987 |
In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazines; Rifampin | 1987 |
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin | 1988 |
Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.
Topics: Anti-Infective Agents; Cefoxitin; Ciprofloxacin; Erythromycin; Fleroxacin; Humans; Legionella; Macrophages; Microbial Sensitivity Tests; Rifampin | 1988 |
In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin | 1988 |
Uptake of ciprofloxacin by macrophages.
Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Ciprofloxacin; Macrophages; Mice; Microbial Sensitivity Tests; Quinolines; Rifampin; Staphylococcus aureus | 1985 |
The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fusidic Acid; Gentamicins; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Quinolines; Rifampin; Staphylococcus aureus; Staphylococcus Phages; Teicoplanin; Vancomycin | 1985 |
The effect of antibiotics on the growth of Legionella pneumophila in guinea-pig alveolar phagocytes infected in vivo by an aerosol.
Topics: Animals; Anti-Bacterial Agents; Cell Division; Ciprofloxacin; Drug Evaluation, Preclinical; Erythromycin; Female; Gentamicins; Guinea Pigs; Legionella; Legionnaires' Disease; Phagocytes; Pulmonary Alveoli; Quinolines; Rifampin | 1985 |
Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Legionella; Rifampin | 1988 |
A description of the outbreak of meningitis in HMS Raleigh in February 1987.
Topics: Adolescent; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Microbial; Humans; Male; Meningitis, Meningococcal; Military Personnel; Naval Medicine; Rifampin; United Kingdom | 1988 |
Comparison of ciprofloxacin and rifampicin in experimental Legionella pneumophila pneumonia.
Topics: Animals; Ciprofloxacin; Drug Therapy, Combination; Female; Guinea Pigs; Legionella; Legionnaires' Disease; Lung; Rifampin; Spleen | 1987 |
Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Osteomyelitis; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin | 1987 |
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.
Topics: Acetaminophen; Adult; Capreomycin; Ciprofloxacin; Drug Combinations; Drug Overdose; Ethambutol; Female; Humans; Isoniazid; Liver; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Different patterns of bacterial DNA synthesis during postantibiotic effect.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; DNA, Bacterial; Escherichia coli; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tobramycin; Vancomycin | 1995 |
Radiometric susceptibility testing of Mycobacterium xenopi.
Topics: Amikacin; Ciprofloxacin; Ethambutol; Microbial Sensitivity Tests; Nontuberculous Mycobacteria; Radiometry; Rifabutin; Rifampin; Streptomycin | 1995 |
Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus aureus; Stereoisomerism | 1994 |
The in-vitro susceptibilities of toxigenic strains of Corynebacterium diphtheriae isolated in northwestern Russia and surrounding areas to ten antibiotics.
Topics: Anti-Bacterial Agents; Baltic States; Ciprofloxacin; Corynebacterium diphtheriae; Erythromycin; Humans; Microbial Sensitivity Tests; Rifampin; Russia | 1994 |
In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Topics: Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 1994 |
Recrudescence and relapse of meningococcal meningitis and septicaemia.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteremia; Child, Preschool; Chloramphenicol; Ciprofloxacin; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Injections, Intravenous; Male; Meningitis, Meningococcal; Methylprednisolone; Penicillin G; Penicillin V; Recurrence; Rifampin; Time Factors | 1995 |
Etest for susceptibility testing of Mycobacterium tuberculosis and Mycobacterium avium-intracellulare.
Topics: Ciprofloxacin; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium tuberculosis; Rifampin | 1994 |
[Combined use of quinolones with other antibiotics in treatment of experimental plague infection].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Lactams; Mice; Pefloxacin; Plague; Rifampin | 1994 |
Infection due to Mycobacterium haemophilum identified by whole cell lipid analysis and nucleic acid sequencing.
Topics: Abscess; Aged; Ciprofloxacin; DNA, Bacterial; DNA, Ribosomal; Drug Therapy, Combination; Fatty Acids; Humans; Lymphoma, Non-Hodgkin; Male; Mycobacterium haemophilum; Mycobacterium Infections; Rifampin | 1994 |
Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin.
Topics: Aged; Arthritis, Rheumatoid; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Humans; Male; Mycobacterium Infections, Nontuberculous; Prednisone; Rifampin; Skin; Vasculitis | 1994 |
The non-aqueous titrimetric assay of selected antibiotics using tetra-N-butylammonium hydroxide as titrant.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Ciprofloxacin; Detergents; Hydrogen-Ion Concentration; Netilmicin; Potentiometry; Quality Control; Quaternary Ammonium Compounds; Reproducibility of Results; Rifampin | 1994 |
Rifampin-resistant Mycobacterium kansasii.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Ciprofloxacin; Clinical Protocols; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Texas; Treatment Outcome; Tuberculosis | 1994 |
Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Topics: Aminocoumarins; Anti-Infective Agents; Ciprofloxacin; Coumarins; DNA Topoisomerases, Type II; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Rifampin | 1994 |
[Ciprofloxacin, clarithromycin, rifampin: in vitro bactericidal activity of double and triple drug combinations against strains of atypical mycobacteria].
Topics: Ciprofloxacin; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Mycobacterium phlei; Nontuberculous Mycobacteria; Rifampin | 1993 |
Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease.
Topics: Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Ciprofloxacin; Clofazimine; Drug Monitoring; Ethambutol; Female; Humans; Male; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin | 1993 |
Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
Topics: Ampicillin Resistance; Animals; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Rifampin; Vancomycin | 1993 |
Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin.
Topics: Animals; Body Weight; Brucella; Brucellosis; Ciprofloxacin; Colony Count, Microbial; Doxycycline; Drug Synergism; Drug Therapy, Combination; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Organ Size; Rifampin; Spleen; Streptomycin | 1993 |
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium; Rifabutin; Rifampin; Rifamycins | 1993 |
Safety of ciprofloxacin in children with cystic fibrosis.
Topics: Administration, Oral; Adolescent; Alkaline Phosphatase; Child; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Joint Diseases; Lung Diseases; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Safety | 1993 |
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Male; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Rifampin; Skin Diseases, Bacterial | 1993 |
Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals. Australian Group on Antimicrobial Resistance (AGAR).
Topics: Australia; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Hospitals, Teaching; Humans; Methicillin; Methicillin Resistance; Penicillins; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 1996 |
In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Ciprofloxacin; Disease Outbreaks; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin Resistance; Rifampin | 1995 |
Mycobacterium avium-intracellulare complex pneumonia in a non-HIV-infected individual: an increasingly recognized disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; HIV Seronegativity; Humans; Male; Mycobacterium avium-intracellulare Infection; Necrosis; Pneumonia, Bacterial; Pulmonary Atelectasis; Rifampin | 1996 |
The antimicrobial susceptibility of Streptococcus pyogenes isolates from the Philadelphia area.
Topics: Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Clindamycin; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillins; Philadelphia; Rifampin; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 1995 |
Uptake of Streptococcus pneumoniae by respiratory epithelial cells.
Topics: Bacterial Adhesion; Bacterial Capsules; Bacterial Proteins; Cells, Cultured; Chloramphenicol; Ciprofloxacin; Cytochalasin D; DNA, Bacterial; Enzyme Inhibitors; Epithelium; Humans; Microscopy, Electron; Pneumococcal Infections; Protein Synthesis Inhibitors; Pulmonary Alveoli; Rifampin; RNA, Bacterial; Streptococcus pneumoniae; Trypsin; Tumor Necrosis Factor-alpha | 1996 |
Determination of the in vivo post-antibiotic effects of ciprofloxacin and rifampicin.
Topics: Animals; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli; Female; Infusions, Intravenous; Injections, Spinal; Meningitis, Bacterial; Microbial Sensitivity Tests; Rabbits; Rifampin | 1995 |
Drug delivery concepts for the efficacious prevention of foreign-body infections.
Topics: Ciprofloxacin; Drug Carriers; Erythromycin; Floxacillin; Microbial Sensitivity Tests; Oxacillin; Polyurethanes; Rifampin; Silicones; Staphylococcus epidermidis | 1996 |
Detection of rifampin- and ciprofloxacin-resistant Mycobacterium tuberculosis by using species-specific assays for precursor rRNA.
Topics: Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oligonucleotide Probes; Phylogeny; Polymerase Chain Reaction; Rifampin; RNA Precursors; RNA, Bacterial; RNA, Ribosomal; Species Specificity | 1996 |
Brodimoprim synergy against Enterococcus faecalis evaluated in vitro.
Topics: Anti-Bacterial Agents; Carbenicillin; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Enzyme Inhibitors; Evaluation Studies as Topic; Folic Acid Antagonists; Gentamicins; Microbial Sensitivity Tests; Rifampin; Trimethoprim | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Prophylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescue.
Topics: Ambulatory Care; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Ciprofloxacin; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasms; Rifampin; Transplantation, Autologous; Treatment Outcome | 1996 |
[Increased effectiveness of etiotropic therapy of experimental plague in albino mice at the stage of generalized infection].
Topics: Amikacin; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Progression; Drug Evaluation, Preclinical; Gentamicins; Mice; Plague; Polymyxins; Rifampin | 1996 |
The effect of aminoglycoside-induced adaptive resistance on the antibacterial activity of other antibiotics against Pseudomonas aeruginosa in vitro.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftazidime; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Microbial; Gentamicins; Imipenem; Piperacillin; Pseudomonas aeruginosa; Rifampin | 1996 |
Non-tuberculous mycobacterial keratitis: a study of 22 cases.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Eye Injuries; Female; Follow-Up Studies; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Postoperative Complications; Retrospective Studies; Rifampin; Treatment Outcome; Visual Acuity | 1996 |
Bactericidal activity of the fluoroquinolone DU-6859a alone and in combination with other antimicrobial agents against multiresistant enterococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; Drug Antagonism; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Enterococcus; Fluoroquinolones; Genetic Variation; Gentamicins; Lactams; Microbial Sensitivity Tests; Novobiocin; Quinolones; Rifampin | 1996 |
The Etest for antimicrobial susceptibility testing of Bartonella henselae.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bartonella henselae; Cats; Ciprofloxacin; Doxycycline; Erythromycin; Humans; Microbial Sensitivity Tests; Rifampin; Vancomycin | 1996 |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Diagnostic Errors; Drug Therapy, Combination; Humans; Mycobacterium Infections; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Vaccines; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Contraindications; Humans; Infant; Meningococcal Infections; Meningococcal Vaccines; Neisseria meningitidis; Rifampin; Vaccination | 1997 |
In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus | 1997 |
[Effect of medium temperature and pH on the sensitivity of pathogenic pseudomonads to chemotherapeutic agents].
Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Culture Media; Doxycycline; Drug Resistance, Microbial; Gentamicins; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Rifampin; Species Specificity; Temperature | 1997 |
In-vitro activity of a new oral streptogramin, RPR 106972, alone and in combination with rifampicin or ciprofloxacin against Legionella spp.
Topics: Ciprofloxacin; Drug Therapy, Combination; Legionella; Microbial Sensitivity Tests; Rifampin; Virginiamycin | 1997 |
In-vitro antibacterial susceptibility of bacteria taken from infected root dentine to a mixture of ciprofloxacin, metronidazole and minocycline.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Bacteria, Anaerobic; Ciprofloxacin; Dental Caries; Dental Pulp Cavity; Dentin; Drug Combinations; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Periapical Diseases; Pulpitis; Rifampin | 1996 |
Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Legionella pneumophila; Microbial Sensitivity Tests; Rifampin | 1997 |
Evaluation of the post-antibiotic effect of six anti-mycobacterial agents against Mycobacterium avium by the Bactec radiometric method.
Topics: Amikacin; Antitubercular Agents; Cell Division; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium avium; Radiometry; Rifampin | 1997 |
[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Naphthyridines; Novobiocin; Rifampin; Sulbactam; Teicoplanin; Vancomycin | 1997 |
In vitro susceptibility of Staphylococcus aureus isolated from blood to currently used antistaphylococcal drugs.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Clindamycin; Cross Infection; Drug Resistance, Microbial; Glycopeptides; Humans; Italy; Oxacillin; Penicillins; Rifampin; Serum Bactericidal Test; Staphylococcal Infections; Staphylococcus aureus | 1998 |
In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Drug Interactions; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Virginiamycin | 1998 |
The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR).
Topics: Anti-Bacterial Agents; Australia; Bacteriophage Typing; Ciprofloxacin; Drug Resistance, Multiple; Endemic Diseases; Fusidic Acid; Hospitals, Teaching; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Prevalence; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 1998 |
Reduced intracellular activity of antibiotics against Listeria monocytogenes in multidrug resistant cells.
Topics: Animals; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Cell Line; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Fibroblasts; Genetic Engineering; Humans; Listeria monocytogenes; Mice; Rifampin; Virginiamycin | 1998 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
[Standardization of the Neisseria meningitidis antibiogram. Detection of strains relatively resistant to penicillin].
Topics: Amoxicillin; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin G; Penicillin Resistance; Penicillins; Rifampin; Spiramycin | 1998 |
Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Fleroxacin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1995 |
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
Topics: Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Ciprofloxacin; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Rifampin; Thienamycins; Tobramycin | 1999 |
In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Gatifloxacin; Legionella; Microbial Sensitivity Tests; Rifampin | 1999 |
The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Aza Compounds; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Legionella; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rifampin | 1999 |
Adsorption and release of antibiotics from morselized cancellous bone. In vitro studies of 8 antibiotics.
Topics: Adsorption; Anti-Bacterial Agents; Biological Assay; Bone Transplantation; Cephalosporins; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Drug Carriers; Drug Evaluation, Preclinical; Drug Stability; Humans; Netilmicin; Penicillin G; Rifampin; Temperature; Time Factors; Transplantation, Homologous; Vancomycin | 1999 |
Reactivation of osteomyelitis caused by Staphylococcus aureus after 50 years.
Topics: Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Femur; Humans; Male; Muscle, Skeletal; Myositis; Osteomyelitis; Recurrence; Rifampin; Staphylococcal Infections | 1999 |
[In vitro sensitivity to five antibiotics of clinical isolated Brucella spp].
Topics: Anti-Bacterial Agents; Brucella; Ciprofloxacin; Doxycycline; Humans; Microbial Sensitivity Tests; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.
Topics: Adult; Africa; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Cloxacillin; Ethambutol; Humans; Leg Ulcer; Male; Metronidazole; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Penicillins; Rifampin; Skin Diseases, Bacterial; Skin Transplantation; Travel; Trimethoprim, Sulfamethoxazole Drug Combination; Virulence | 1999 |
[Oral antibiotic therapy in the adult bacterial osteomyelitis: results after two years of follow-up].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotics, Antitubercular; Bacterial Infections; Ciprofloxacin; Combined Modality Therapy; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Osteomyelitis; Prospective Studies; Rifampin; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Drug Resistance, Multiple; Erythromycin; Humans; Legionella; Microbial Sensitivity Tests; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Species Specificity | 2000 |
Helicobacter cinaedi septic arthritis and bacteremia in an immunocompetent patient.
Topics: Adult; Anti-Infective Agents; Arthritis, Infectious; Bacteremia; Ciprofloxacin; Helicobacter; Helicobacter Infections; Humans; Immunocompetence; Male; Rifampin; Synovitis | 2000 |
[Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
Topics: Adolescent; Adult; Bacterial Vaccines; Carrier State; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Microbial; Humans; Incidence; Infant; Meningococcal Infections; Meningococcal Vaccines; Microbial Sensitivity Tests; National Health Programs; Neisseria meningitidis; Rifampin; Spain; Sulfadiazine; Time Factors; Vaccination | 2000 |
Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
Topics: Agar; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin | 2000 |
Evaluation of a human monocytic cell line THP-1 model for assay of the intracellular activities of antimicrobial agents against Legionella pneumophila.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cell Line; Ciprofloxacin; Erythromycin; Humans; Legionella pneumophila; Microbial Sensitivity Tests; Minocycline; Monocytes; Rifampin | 2000 |
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Humans; Imipenem; Methicillin Resistance; Nisin; Peptides, Cyclic; Rana catesbeiana; Rifampin; Staphylococcus aureus; Vancomycin | 2000 |
Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA-Directed RNA Polymerases; Drug Resistance, Multiple; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Rifampin; Staphylococcus aureus | 2000 |
A case of costochondral abscess due to Corynebacterium minutissimum in an HIV-infected patient.
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Drug Resistance, Multiple; HIV Infections; HIV-1; Humans; Male; Penicillins; Ribs; Rifampin; Tomography, X-Ray Computed; Vancomycin | 2000 |
Development of chromosomally encoded resistance mutations in small-colony variants of Staphylococcus aureus.
Topics: Anti-Infective Agents; Chromosomes, Bacterial; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus | 2001 |
Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Base Sequence; Ciprofloxacin; Clarithromycin; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Microbial; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Rifampin; Transformation, Bacterial | 2001 |
Antimicrobial resistance of Enterococci in Lebanon.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gentamicins; Humans; Lebanon; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Rifampin; Streptomycin; Teicoplanin; Tetracycline; Vancomycin | 2001 |
Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep.
Topics: Amoxicillin; Animal Feed; Animals; Anti-Bacterial Agents; Brain; Cephalosporins; Cephalothin; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Gentamicins; Kanamycin; Listeria monocytogenes; Listeriosis; Meningoencephalitis; Microbial Sensitivity Tests; Penicillin G; Penicillins; Rifampin; Sheep; Sheep Diseases; Sulfisoxazole; Tetracycline; Trimethoprim; Vancomycin | 2001 |
MAC management.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Tuberculin Test; Zidovudine | 1996 |
Treatment of staphylococcal implant infection with rifampicin-ciprofloxacin in stable implants.
Topics: Anti-Bacterial Agents; Blood Sedimentation; C-Reactive Protein; Ciprofloxacin; Debridement; Drug Therapy, Combination; Humans; Knee Prosthesis; Male; Middle Aged; Prosthesis Failure; Prosthesis-Related Infections; Reoperation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis | 2001 |
Investigation of Smith's quinolone killing mechanisms during the PAE of ciprofloxacin on Escherichia coli.
Topics: Anti-Infective Agents; Cell Survival; Cells, Cultured; Chloramphenicol; Ciprofloxacin; Drug Interactions; Escherichia coli; Protein Synthesis Inhibitors; Rifampin | 2001 |
Failures of rifampicin and ciprofloxacin to eradicate a susceptible meningococcal isolate from a close contact of a fatal case.
Topics: Adolescent; Anti-Infective Agents; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Ciprofloxacin; Disease Transmission, Infectious; Drug Resistance, Bacterial; Female; Humans; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Rifampin | 2001 |
[Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study].
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Drug Resistance; Fluoroquinolones; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Naphthyridines; Nasopharynx; Neisseria meningitidis; Respiratory Tract Infections; Rifampin; Time Factors | 2001 |
Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients.
Topics: Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bioterrorism; Blood; Ciprofloxacin; Clindamycin; District of Columbia; Dyspnea; Fever; Humans; Lymphatic Diseases; Male; Mediastinal Diseases; Middle Aged; Occupational Exposure; Pleural Effusion; Polymerase Chain Reaction; Postal Service; Radiography, Thoracic; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survivors; Tomography, X-Ray Computed | 2001 |
Anthrax. A 'sure killer' yields to medicine.
Topics: Adult; Anthrax; Bacillus anthracis; Child; Ciprofloxacin; Clindamycin; Disease Susceptibility; Drug Therapy, Combination; Female; History, 20th Century; History, 21st Century; Humans; Male; Pleural Effusion; Prognosis; Rifampin; Russia; United States | 2001 |
Variations in chemoprophylaxis for meningococcal disease: a retrospective case note review, analysis of routine prescribing data and questionnaire of general practitioners.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Antibiotics, Antitubercular; Ciprofloxacin; Contact Tracing; Drug Utilization Review; Family Practice; Humans; Medical Staff, Hospital; Meningococcal Infections; Physicians, Family; Practice Patterns, Physicians'; Retrospective Studies; Rifampin; Surveys and Questionnaires; United Kingdom | 2001 |
What about antibiotic resistance in Neisseria lactamica?
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Neisseria; Neisseriaceae Infections; Penicillins; Rifampin | 2002 |
Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Microbial Sensitivity Tests; Mutation; Rifampin | 2002 |
Conservative medical therapy of infections following osteosynthesis: a retrospective analysis of a six-year experience.
Topics: Adolescent; Adult; Aged; Ciprofloxacin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Follow-Up Studies; Fracture Fixation, Internal; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Surgical Wound Infection; Teicoplanin | 2002 |
In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Fusidic Acid; Gentamicins; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus aureus; Vancomycin | 2003 |
Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
Topics: Bacteriological Techniques; Burkholderia cepacia; Burkholderia Infections; Ceftazidime; Chi-Square Distribution; Child; Child, Preschool; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lactams; Male; Microbial Sensitivity Tests; Piperacillin; Rifampin; Sensitivity and Specificity | 2003 |
High-efficiency generation of antibiotic-resistant strains of Streptococcus pneumoniae by PCR and transformation.
Topics: Amino Acid Sequence; Ciprofloxacin; Drug Resistance, Bacterial; Molecular Sequence Data; Polymerase Chain Reaction; Rifampin; Streptococcus pneumoniae; Streptomycin; Transformation, Bacterial | 2003 |
[Ciprofloxacin in the treatment of patients with brucellosis].
Topics: Acute Disease; Adult; Antibody Formation; Brucella melitensis; Brucellosis; Chronic Disease; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Humans; Middle Aged; Rifampin; Severity of Illness Index; Treatment Outcome | 2002 |
[Relapsing Staphylococcus lugdunensis septic arthritis associated with a knee prosthesis].
Topics: Aged; Arthritis, Infectious; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Autoimmune Diseases; Ciprofloxacin; Cloxacillin; Drug Therapy, Combination; Fatal Outcome; Humans; Immunocompromised Host; Knee Prosthesis; Male; Phlebitis; Postoperative Complications; Prosthesis-Related Infections; Pulmonary Embolism; Recurrence; Rifampin; Staphylococcal Infections; Staphylococcus; Virulence | 2003 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
Topics: Ampicillin; Animals; Base Sequence; Cell Line; Chloramphenicol; Ciprofloxacin; Coxiella burnetii; DNA, Bacterial; Drug Resistance, Bacterial; Fluorescent Antibody Technique; Humans; Mice; Microbial Sensitivity Tests; Polymerase Chain Reaction; Q Fever; Rifampin; Tetracycline | 2003 |
Biotypes and antimicrobial susceptibilities of Brucella isolates.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Brucella melitensis; Brucellosis; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Rifampin; Sensitivity and Specificity; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey | 2003 |
Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Biofilms; Catheterization; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Monitoring; Luminescent Measurements; Mice; Rifampin; Staphylococcus aureus; Tobramycin | 2003 |
Hepatic abscess in brucellosis: a case report.
Topics: Brucellosis; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Liver Abscess; Middle Aged; Rifampin; Severity of Illness Index; Tetracycline; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler | 2003 |
Experimental study of clinafloxacin alone and in combination in the treatment of ciprofloxacin-susceptible and -resistant pneumococcal meningitis.
Topics: Animals; Cerebrospinal Fluid; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Rabbits; Rifampin; Streptococcus pneumoniae; Teicoplanin; Treatment Outcome | 2003 |
[Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Topics: Acetamides; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2003 |
Oxygen tension regulates reactive oxygen generation and mutation of Helicobacter pylori.
Topics: Aerobiosis; Anaerobiosis; Bacterial Proteins; Ciprofloxacin; Cytochromes c; DNA; Drug Resistance; Guanine; Helicobacter pylori; Metronidazole; Mutation; Oxidative Stress; Oxygen; Reactive Oxygen Species; Rifampin; Superoxide Dismutase; Urease | 2004 |
A case of mitral stenosis complicated with seronegative Brucella endocarditis.
Topics: Adult; Brucella melitensis; Brucellosis; Ciprofloxacin; Combined Modality Therapy; Doxycycline; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Mitral Valve Stenosis; Rifampin | 2004 |
Severe bilateral optic neuritis associated with prolonged linezolid therapy.
Topics: Acetamides; Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Female; Functional Laterality; Humans; Linezolid; Optic Neuritis; Oxazolidinones; Prosthesis-Related Infections; Rifampin | 2004 |
["Actinobacillus and Haemophilus parainfluenzae infective endocarditis: two case reports"].
Topics: Actinobacillus Infections; Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Follow-Up Studies; Haemophilus Infections; Haemophilus parainfluenzae; Humans; Male; Middle Aged; Pleural Effusion; Rifampin; Time Factors; Treatment Outcome | 2004 |
[Early diagnosis of Legionella pneumonia with mental disturbance by urinary antigen].
Topics: Antigens, Bacterial; Biomarkers; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, Combination; Erythromycin; Humans; Legionella pneumophila; Legionnaires' Disease; Male; Mental Disorders; Middle Aged; Rifampin; Serologic Tests; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Drug-sensitivity profile of clinical Mycobacterium tuberculosis isolates--a retrospective study from a chest-disease institute in India.
Topics: Adult; Aged; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Retrospective Studies; Rifampin; Sputum; Treatment Failure; Tuberculosis, Pulmonary | 2005 |
Inhibition of mutation and combating the evolution of antibiotic resistance.
Topics: Animals; Bacterial Proteins; Ciprofloxacin; Disease Models, Animal; DNA Damage; DNA, Bacterial; Drug Resistance; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Evolution, Molecular; Mice; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Rifampin; Serine Endopeptidases | 2005 |
[Two cases of pulmonary infection by Mycobacterium abscessus in which drug susceptibility testing results conflicted with clinical courses].
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Humans; Male; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Rifampin | 2005 |
Identification of Lactobacillus ruminus SPM0211 isolated from healthy Koreans and its antimicrobial activity against some pathogens.
Topics: Adult; Base Sequence; Ciprofloxacin; DNA Fingerprinting; Drug Resistance, Bacterial; Enterococcus; Ethambutol; Feces; Humans; Korea; Lactobacillus; Microbial Sensitivity Tests; Molecular Sequence Data; Probiotics; Random Amplified Polymorphic DNA Technique; Rifampin; Staphylococcus aureus; Streptomycin; Time Factors; Vancomycin | 2005 |
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2005 |
Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Debridement; Drug Therapy, Combination; Female; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Prosthesis-Related Infections; Rifampin | 2005 |
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin | 2005 |
Characteristics of Haemophilus influenzae type b responsible for meningitis in Poland from 1997 to 2004.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Haemophilus influenzae type b; Humans; Meningitis; Microbial Sensitivity Tests; Poland; Rifampin | 2005 |
Sampling the antibiotic resistome.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Ketolides; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Rifampin; Soil Microbiology; Streptomyces; Trimethoprim Resistance; Vancomycin Resistance; Virginiamycin | 2006 |
Pasteurella multocida infection of a total knee arthroplasty after a "dog lick".
Topics: Aged; Amoxicillin; Animals; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Ciprofloxacin; Dogs; Doxycycline; Drug Therapy, Combination; Female; Humans; Knee Prosthesis; Pasteurella Infections; Pasteurella multocida; Prosthesis-Related Infections; Recurrence; Reoperation; Rifampin; Synovectomy | 2006 |
Comparative study of antimicrobial release kinetics from polymethylmethacrylate.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Cefazolin; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Linezolid; Ofloxacin; Oxazolidinones; Polymethyl Methacrylate; Rifampin | 2006 |
Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Quinolines; Rifampin; Tuberculosis, Pulmonary | 2006 |
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Topics: Adult; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Israel; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Ofloxacin; Prognosis; Rifampin | 2006 |
Comparative in vitro efficacies of various catheter lock solutions.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anticoagulants; Candida albicans; Catheterization; Catheters, Indwelling; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Edetic Acid; Ethanol; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Pharmaceutical Preparations; Pseudomonas aeruginosa; Rifampin; Solutions; Staphylococcus aureus; Staphylococcus epidermidis; Taurine; Thiadiazines; Time Factors; Vancomycin | 2006 |
[Synergistic action of some antibacterial agents in studies on albino mice with experimental plague caused by Fr- phenotype strain of the plague microbe].
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Mice; Mice, Inbred Strains; Plague; Rifampin; Yersinia pestis | 2006 |
Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapy.
Topics: Adult; Animals; Anti-Infective Agents; Antimony; Antiprotozoal Agents; Cartilage; Ciprofloxacin; Ear, External; Humans; Immunocompetence; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pseudomonas Infections; Rifampin | 2006 |
[E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].
Topics: Anti-Bacterial Agents; Brucella; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Rifampin; Streptomycin; Tetracycline | 2006 |
[A case of brucellosis presenting with urinary tract infection].
Topics: Acute Disease; Adult; Anti-Infective Agents; Brucella melitensis; Brucellosis; Ciprofloxacin; Humans; Male; Rifampin; Urinary Tract Infections | 2006 |
[Community-acquired methicillin-resistant Staphylococcus aureus disseminated disease].
Topics: Abscess; Adult; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Humans; Male; Methicillin Resistance; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus | 2006 |
The effects of anti-bacterials on the malaria parasite Plasmodium falciparum.
Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Ciprofloxacin; Clindamycin; DNA Replication; Malaria, Falciparum; Plasmodium falciparum; Protein Biosynthesis; Rifampin; Tetracycline; Thiostrepton; Time Factors; Transcription, Genetic | 2007 |
Molecular mechanisms of resistance to antibiotics in Bartonella bacilliformis.
Topics: Anti-Bacterial Agents; Bartonella bacilliformis; Bartonella Infections; Base Sequence; Ciprofloxacin; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Erythromycin; Humans; Models, Molecular; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Rifampin | 2007 |
In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp.
Topics: Adult; Anti-Bacterial Agents; Brucella; Brucellosis; Ciprofloxacin; Doxycycline; Humans; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline | 2007 |
Identification of a novel streptococcal gene cassette mediating SOS mutagenesis in Streptococcus uberis.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; Blotting, Northern; Ciprofloxacin; DNA Damage; Drug Resistance, Bacterial; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Bacterial; Genes, Bacterial; Mitomycin; Models, Genetic; Molecular Sequence Data; Mutagenesis; Mutation; Operon; Rifampin; Sequence Homology, Nucleic Acid; SOS Response, Genetics; Streptococcus; Ultraviolet Rays | 2007 |
Evaluation of a tool to benchmark hospital antibiotic prescribing in the United Kingdom.
Topics: Anti-Bacterial Agents; Benchmarking; Cefuroxime; Ciprofloxacin; Cohort Studies; Data Collection; Drug Prescriptions; Drug Utilization; Hospitals; Humans; Isoniazid; Medication Systems, Hospital; Pharmacy Service, Hospital; Pilot Projects; Practice Guidelines as Topic; Practice Patterns, Physicians'; Rifampin; United Kingdom | 2008 |
Septic arthritis with Staphylococcus lugdunensis following arthroscopic ACL revision with BPTB allograft.
Topics: Adult; Anterior Cruciate Ligament; Anterior Cruciate Ligament Injuries; Anti-Infective Agents; Arthritis, Infectious; Arthroscopy; Bone-Patellar Tendon-Bone Grafting; Ciprofloxacin; Humans; Knee Joint; Male; Reoperation; Rifampin; Staphylococcal Infections; Staphylococcus; Surgical Wound Infection; Transplantation, Autologous | 2008 |
Laparoscopic diagnosis and treatment of aortic vascular prosthetic graft infections in a porcine model.
Topics: Animals; Anti-Bacterial Agents; Aorta; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Ciprofloxacin; Debridement; Disease Models, Animal; Drug Therapy, Combination; Feasibility Studies; Female; Laparoscopy; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Swine; Time Factors | 2008 |
Brucellosis, an uncommon and frequently delayed diagnosis.
Topics: Adult; Aged; Arthralgia; Back Pain; Brucellosis; Ciprofloxacin; Diagnosis, Differential; Doxycycline; Drug Therapy, Combination; Dyspnea; Female; Humans; India; Male; Middle Aged; Netherlands; Rifampin; Turkey | 2007 |
Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative cases.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Antibodies, Monoclonal; Anticoagulants; Autoantibodies; Ciprofloxacin; Drug Therapy, Combination; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; Immunoglobulin G; Male; Middle Aged; Myocardial Infarction; Osteomyelitis; Purpura, Thrombocytopenic, Idiopathic; Rifampin | 2008 |
Mutant prevention concentrations of tetracycline, rifampicin and ciprofloxacin for Brucellae melitensis.
Topics: Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Ciprofloxacin; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mutation; Rifampin; Tetracycline | 2007 |
Short report: edematous Mycobacterium ulcerans infection (Buruli ulcer) on the face: a case report.
Topics: Angola; Anti-Bacterial Agents; Buruli Ulcer; Child, Preschool; Ciprofloxacin; Edema; Humans; Male; Mycobacterium ulcerans; Necrosis; Rifampin; Treatment Outcome | 2007 |
In brief: Meningococcal prophylaxis.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Meningococcal Infections; Meningococcal Vaccines; Minnesota; Neisseria meningitidis; North Dakota; Rifampin | 2008 |
Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Genes, Bacterial; Gentamicins; Metronidazole; Microbial Sensitivity Tests; Mutation; Rifampin; Sulfamethoxazole; Vancomycin | 2008 |
Polyester vascular prostheses coated with a cyclodextrin polymer and activated with antibiotics: cytotoxicity and microbiological evaluation.
Topics: Anti-Bacterial Agents; Blood Vessel Prosthesis; Cell Survival; Cellulose; Ciprofloxacin; Cyclodextrins; Enterococcus; Escherichia coli; Humans; Microbial Sensitivity Tests; Polyesters; Prosthesis Design; Rifampin; Spectrophotometry; Staphylococcus aureus; Vancomycin | 2008 |
Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Chloramphenicol; Chromosomes, Bacterial; Ciprofloxacin; Colistin; Escherichia coli; Fosfomycin; Gentamicins; Imipenem; Microbial Sensitivity Tests; Recombination, Genetic; Rifampin; Tetracycline; Trimethoprim | 2009 |
[High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children].
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Spain; Tetracycline | 2009 |
Disseminated infection with Bartonella henselae in a lung transplant recipient.
Topics: Adult; Anti-Bacterial Agents; Bartonella henselae; Cat-Scratch Disease; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Lung; Lung Transplantation; Magnetic Resonance Imaging; Rifampin; Treatment Outcome | 2009 |
Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK.
Topics: Adult; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Gastritis; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Rifampin; United Kingdom | 2009 |
[Biological and molecular characteristics of a cat-borne Bartonella clarridgeiae].
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; Bartonella; Cats; Cefotaxime; Ciprofloxacin; Electrophoresis, Gel, Pulsed-Field; Microbial Sensitivity Tests; Phylogeny; Random Amplified Polymorphic DNA Technique; Rifampin; RNA, Ribosomal, 16S | 2009 |
Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Synergism; Gentamicins; Lipoglycopeptides; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Rifampin; Thienamycins; Time Factors | 2010 |
Efficacy of prolonged antimicrobial chemotherapy for brucellar spondylodiscitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Brucella; Ciprofloxacin; Discitis; Doxycycline; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Rifampin; Streptomycin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Hypermutability in clinical isolates of Klebsiella pneumoniae is uncommon and is unrelated to ciprofloxacin resistance.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; London; Microbial Sensitivity Tests; Mutation; Rifampin; Streptomycin | 2010 |
Detection of the cell wall-affecting antibiotics at sublethal concentrations using a reporter Staphylococcus aureus harboring drp35 promoter - lacZ transcriptional fusion.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Galactosidase; Carrier Proteins; Cell Wall; Ciprofloxacin; High-Throughput Screening Assays; Hydrolases; Microbial Sensitivity Tests; Promoter Regions, Genetic; Recombinant Fusion Proteins; Rifampin; Staphylococcus aureus | 2010 |
Antimicrobial susceptibility of Brucella melitensis isolates in Peru.
Topics: Anti-Infective Agents; Azithromycin; Brucella melitensis; Brucellosis; Ciprofloxacin; Doxycycline; Gentamicins; Humans; Microbial Sensitivity Tests; Peru; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Environmental mutagens may be implicated in the emergence of drug-resistant microorganisms.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzopyrenes; Carmustine; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Ethyl Methanesulfonate; Methylurea Compounds; Nitrosamines; Polymerase Chain Reaction; Pseudomonas aeruginosa; Rifampin | 2011 |
Chemical and antimicrobial treatments change the viscoelastic properties of bacterial biofilms.
Topics: Biofilms; Cations; Ciprofloxacin; Disinfectants; Elasticity; Glutaral; Materials Testing; Models, Theoretical; Pseudomonas aeruginosa; Rheology; Rifampin; Staphylococcus epidermidis; Urea; Viscosity | 2011 |
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Ciprofloxacin; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2011 |
Antimicrobial susceptibility of Neisseria meningitidis strains isolated from meningitis cases in Brazil from 2006 to 2008.
Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactams; Brazil; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Rifampin; Serotyping; Species Specificity; Young Adult | 2011 |
Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus | 2011 |
Surfactant free rapid synthesis of hydroxyapatite nanorods by a microwave irradiation method for the treatment of bone infection.
Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Bacterial Adhesion; Bone and Bones; Bone Diseases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Ciprofloxacin; Durapatite; Escherichia coli; Humans; Microbial Sensitivity Tests; Microwaves; Nanotechnology; Nanotubes; Rifampin; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Staphylococcus epidermidis; Surface Properties; Surface-Active Agents; X-Ray Diffraction | 2011 |
The need for better data about counterfeit drugs in developing countries: a proposed standard research methodology tested in Chennai, India.
Topics: Artemisinins; Artesunate; Chromatography, Liquid; Ciprofloxacin; Counterfeit Drugs; Developing Countries; Drug Contamination; Drug Stability; Drug Storage; Humans; India; Mass Spectrometry; Quality Control; Research Design; Rifampin | 2011 |
Bone marrow infection with Mycobacterium fortuitum in a diabetic patient.
Topics: Amikacin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bone Marrow; Bone Marrow Diseases; Ciprofloxacin; Diabetes Mellitus, Type 2; Humans; Isoniazid; Male; Middle Aged; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Rifampin; Treatment Outcome | 2011 |
Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Contact Tracing; Drug Therapy, Combination; Humans; Male; Mycobacterium haemophilum; Mycobacterium Infections; Rifampin; Skin Diseases, Bacterial; Tattooing; Treatment Outcome; Washington | 2011 |
Does a DNA-less cellular organism exist on Earth?
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Archaea; Bacteria; Bacterial Typing Techniques; Benzimidazoles; Ciprofloxacin; Colony Count, Microbial; DNA; DNA Replication; Earth, Planet; Fluorescent Dyes; Hot Springs; Microscopy; Rifampin; RNA; Seawater; Soil Microbiology; Staining and Labeling; Water Microbiology | 2011 |
Nosocomial outbreak of Myroides odoratimimus urinary tract infection in a Tunisian hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Male; Middle Aged; Molecular Typing; Rifampin; Tunisia; Urinary Tract Infections; Urine | 2012 |
Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Colony Count, Microbial; Enterococcus faecalis; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Rifampin | 2012 |
Safety, healing, and efficacy of vascular prostheses coated with hydroxypropyl-β-cyclodextrin polymer: experimental in vitro and animal studies.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Anti-Bacterial Agents; beta-Cyclodextrins; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Ciprofloxacin; Coated Materials, Biocompatible; Dogs; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemolysis; Humans; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Mice; Platelet Aggregation; Prosthesis-Related Infections; Rifampin; Toxicity Tests; Treatment Outcome; Vancomycin; Wound Healing | 2012 |
A simple and economical in-house phage technique for the rapid detection of rifampin, isoniazid, ethambutol, streptomycin, and ciprofloxacin drug resistance in Mycobacterium tuberculosis, directly on decontaminated sputum samples.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Ciprofloxacin; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Mycobacteriophages; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Virus Replication; Young Adult | 2012 |
Rifampicin-soaked silver polyester versus expanded polytetrafluoro-ethylene grafts for in situ replacement of infected grafts in a porcine randomised controlled trial.
Topics: Animals; Anti-Bacterial Agents; Aorta, Abdominal; Biocompatible Materials; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Ciprofloxacin; Device Removal; Disease Models, Animal; Polyesters; Polymers; Polytetrafluoroethylene; Prosthesis-Related Infections; Reoperation; Rifampin; Silver Compounds; Staphylococcal Infections; Staphylococcus aureus; Swine | 2012 |
Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin.
Topics: Adult; Allergens; Ciprofloxacin; Clarithromycin; Female; Humans; Male; Middle Aged; Regional Blood Flow; Rifampin; Skin Test End-Point Titration; Young Adult | 2012 |
The Colour Test for drug susceptibility testing of Mycobacterium tuberculosis strains.
Topics: Antitubercular Agents; Ciprofloxacin; Color; Drug Resistance, Multiple, Bacterial; Estonia; Extensively Drug-Resistant Tuberculosis; Feasibility Studies; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant | 2012 |
In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Bacteriophages; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant | 2012 |
Biomaterials immobilized with chitosan for rechargeable antimicrobial drug delivery.
Topics: Animals; Anti-Infective Agents; Bacteria; Biocompatible Materials; Biofilms; Cell Survival; Chitosan; Ciprofloxacin; Drug Delivery Systems; Fibroblasts; Membranes, Artificial; Microbial Sensitivity Tests; Ozone; Polyurethanes; Rats; Rats, Sprague-Dawley; Rifampin; Surface Properties; Time Factors | 2013 |
Pharmacokinetic and safety evaluation of the use of ciprofloxacin on an isoniazid-rifampicin regimen in rabbits.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antibiotics, Antitubercular; Aspartate Aminotransferases; Bilirubin; Ciprofloxacin; Drug Combinations; Isoniazid; Male; Rabbits; Rifampin | 2012 |
Susceptibility of Wolbachia, an endosymbiont of Brugia malayi microfilariae, to doxycycline determined by quantitative PCR assay.
Topics: Animals; Anti-Bacterial Agents; Brugia malayi; Cell Migration Assays; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Microfilariae; Polymerase Chain Reaction; Rifampin; Time Factors; Wolbachia | 2012 |
Renal cyst infection caused by Brucella abortus.
Topics: Brucella abortus; Brucellosis; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Emergency Service, Hospital; Flank Pain; Follow-Up Studies; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Middle Aged; Polycystic Kidney Diseases; Rifampin; Treatment Outcome | 2013 |
PolA1, a putative DNA polymerase I, is coexpressed with PerR and contributes to peroxide stress defenses of group A Streptococcus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Damage; DNA Polymerase I; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Genetic Variation; Genome, Bacterial; Hydrogen Peroxide; Mutation; Naphthoquinones; Repressor Proteins; Rifampin; Streptococcus pyogenes; Ultraviolet Rays | 2013 |
Rapid antimicrobial susceptibility testing by sensitive detection of precursor rRNA using a novel electrochemical biosensing platform.
Topics: Anti-Infective Agents; Biosensing Techniques; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Electrochemical Techniques; Escherichia coli; Microbial Sensitivity Tests; Rifampin; RNA Precursors; RNA, Ribosomal; Topoisomerase II Inhibitors | 2013 |
Polymorphic mutation frequencies in clinical isolates of Staphylococcus aureus: the role of weak mutators in the development of fluoroquinolone resistance.
Topics: Animals; Cattle; Ciprofloxacin; DNA Gyrase; DNA Mismatch Repair; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genes, Bacterial; Mastitis, Bovine; Microbial Sensitivity Tests; Mutation Rate; Rifampin; Staphylococcus aureus | 2013 |
A comparison between doxycycline-rifampin and ciprofloxacin-rifampin regimens in the treatment of acute Brucellosis.
Topics: Acute Disease; Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Follow-Up Studies; Humans; Incidence; Iran; Prospective Studies; Rifampin; Treatment Outcome | 2011 |
In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Ciprofloxacin; DNA Primers; Gentamicins; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Rifampin; Sheep; Sheep Diseases; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim; Turkey | 2013 |
Roles of the superoxide dismutase SodB and the catalase KatA in the antibiotic resistance of Campylobacter jejuni.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Campylobacter jejuni; Catalase; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Gene Knockout Techniques; Genes, Bacterial; Microbial Sensitivity Tests; Microbial Viability; Mutation; Oxidative Stress; Rifampin; Superoxide Dismutase | 2013 |
Septic shock due to Rhodococcus equi in a patient with chronic myelomonocytic leukemia.
Topics: Actinomycetales Infections; Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, Combination; Fertilizers; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Chronic; Lung Abscess; Lung Neoplasms; Male; Manure; Opportunistic Infections; Rhodococcus equi; Rifampin; Shock, Septic; Tomography, X-Ray Computed | 2013 |
Sacro-iliac osteomyelitis in a 13 year old boy following perforated appendicitis.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendectomy; Appendicitis; Ascitic Fluid; Ciprofloxacin; Clindamycin; Gram-Negative Bacteria; Humans; Laparotomy; Magnetic Resonance Imaging; Male; Metronidazole; Osteomyelitis; Rifampin; Rupture, Spontaneous; Sacroiliitis | 2013 |
Mycobacterium ulcerans disease: experience with primary oral medical therapy in an Australian cohort.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Australia; Buruli Ulcer; Ciprofloxacin; Clarithromycin; Cohort Studies; Debridement; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Retrospective Studies; Rifampin; Treatment Outcome | 2013 |
The mevalonate auxotrophic mutant of Staphylococcus aureus can adapt to mevalonate depletion.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Colony Count, Microbial; Daptomycin; Gene Deletion; Genetic Complementation Test; Gentamicins; Ligases; Mevalonic Acid; Microbial Sensitivity Tests; Polyisoprenyl Phosphates; Rifampin; Staphylococcus aureus | 2013 |
Combination of alpha-melanocyte stimulating hormone with conventional antibiotics against methicillin resistant Staphylococcus aureus.
Topics: 3T3 Cells; alpha-MSH; Animals; Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Ciprofloxacin; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Synergism; Fibroblasts; Gentamicins; Hemolysis; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Microbial Viability; Oxacillin; Rifampin; RNA, Bacterial; Tetracycline | 2013 |
A study comparing the efficacy of antimicrobial agents versus enzyme (P-gp) inducers in the treatment of 2,4,6 trinitrobenzenesulfonic acid-induced colitis in rats.
Topics: Animals; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Ciprofloxacin; Colitis; Colon; Glutathione; Ileum; Male; Malondialdehyde; NF-kappa B; Peroxidase; Pregnane X Receptor; Rats; Rats, Sprague-Dawley; Receptors, Steroid; Rifampin; Spironolactone; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2013 |
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ciprofloxacin; Colistin; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; In Vitro Techniques; Klebsiella pneumoniae; Lipoglycopeptides; Meropenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Thienamycins; Tigecycline; Vancomycin | 2014 |
Antibiotic resistance and capacity for biofilm formation of different bacteria isolated from endodontic infections associated with root-filled teeth.
Topics: Actinomyces; Actinomyces viscosus; Amoxicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Dental Pulp Diseases; Doxycycline; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Fosfomycin; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Limosilactobacillus fermentum; Moxifloxacin; Penicillin G; Penicillin Resistance; Prevotella; Propionibacterium; Rifampin; Streptococcus mutans; Tetracycline Resistance; Tooth, Nonvital; Vancomycin Resistance | 2014 |
Clinical challenges related to novel oral anticoagulants: drug-drug interactions and monitoring.
Topics: Aged; Antibiotics, Antitubercular; Anticoagulants; Atrial Fibrillation; Ciprofloxacin; Coronary Artery Bypass; Drug Incompatibility; Female; Humans; Morpholines; Rifampin; Rivaroxaban; Thiophenes | 2014 |
[In vivo evaluation of the metabolic ratio of CYP2C9 and CYP1A2 drug markers after administration of afobazole in comparison to standard inducers and inhibitors of cytochromes].
Topics: Animals; Anti-Anxiety Agents; Anti-Bacterial Agents; Anticonvulsants; Antifungal Agents; Benzimidazoles; Ciprofloxacin; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Cytochromes; Enzyme Induction; Enzyme Inhibitors; Fluconazole; Male; Morpholines; Phenytoin; Rats; Rifampin | 2013 |
Effective removal of staphylococcal biofilms by the endolysin LysH5.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Endopeptidases; Microbial Sensitivity Tests; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Staphylococcus Phages | 2014 |
Australian Meningococcal Surveillance Programme annual report, 2013.
Topics: Adolescent; Adult; Age Distribution; Aged; Annual Reports as Topic; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Epidemiological Monitoring; Gene Expression; Genotype; Humans; Infant; Meningococcal Infections; Microbial Sensitivity Tests; Middle Aged; Neisseria meningitidis; Penicillins; Phenotype; Porins; Rifampin; Serotyping | 2014 |
Mycobacterium ulcerans treatment--can antibiotic duration be reduced in selected patients?
Topics: Adjuvants, Immunologic; Adult; Aged; Antibiotics, Antitubercular; Australia; Buruli Ulcer; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium ulcerans; Retrospective Studies; Rifampin; Risk Factors; Treatment Outcome; Withholding Treatment | 2015 |
Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; Bacterial Proteins; Binding Sites; Biological Transport; Caco-2 Cells; Ciprofloxacin; Coumarins; Dogs; Ethidium; Humans; Madin Darby Canine Kidney Cells; Mice, Inbred BALB C; Models, Molecular; Multidrug Resistance-Associated Proteins; Pyrroles; Rifampin; Staphylococcus aureus | 2015 |
Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Cloxacillin; Drug Therapy, Combination; Female; Finland; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Secondary Prevention; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Time-to-Treatment; Treatment Outcome | 2015 |
Differential roles of antimicrobials in the acquisition of drug resistance through activation of the SOS response in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Meropenem; Microbial Sensitivity Tests; Mutagenesis; Rifampin; SOS Response, Genetics; Tetracyclines; Thienamycins | 2015 |
Multiple antibiotic susceptibility of polyphosphate kinase mutants (ppk1 and ppk2) from Pseudomonas aeruginosa PAO1 as revealed by global phenotypic analysis.
Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Microarray Analysis; Mutation; Phenotype; Phosphotransferases (Phosphate Group Acceptor); Polyphosphates; Pseudomonas aeruginosa; Rifampin; Virulence | 2015 |
Pre-emptive steroids for a severe oedematous Buruli ulcer lesion: a case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Buruli Ulcer; Ciprofloxacin; Drug Therapy, Combination; Edema; Female; Humans; Prednisolone; Rifampin | 2015 |
Antimicrobial Disk Susceptibility Testing of Leptospira spp. Using Leptospira Vanaporn Wuthiekanun (LVW) Agar.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Leptospira; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
A rare presentation of Legionnaires' disease.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Ciprofloxacin; Community-Acquired Infections; Diagnosis, Differential; Dysuria; Flank Pain; Humans; Legionnaires' Disease; Male; Middle Aged; Pneumonia; Pyelonephritis; Rifampin | 2015 |
Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Debridement; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prosthesis Retention; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Risk Factors; Treatment Failure; Treatment Outcome | 2015 |
Reduced Susceptibility to Rifampicin and Resistance to Multiple Antimicrobial Agents among Brucella abortus Isolates from Cattle in Brazil.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Brazil; Brucella abortus; Brucellosis; Cattle; Ciprofloxacin; DNA, Bacterial; Doxycycline; Drug Resistance, Multiple, Bacterial; Genotype; Gentamicins; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin | 2015 |
Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Cross Infection; Doxycycline; Drug Resistance, Multiple, Bacterial; Fusidic Acid; Humans; Joint Prosthesis; Linezolid; Microbial Sensitivity Tests; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis | 2015 |
Clinically Relevant Growth Conditions Alter Acinetobacter baumannii Antibiotic Susceptibility and Promote Identification of Novel Antibacterial Agents.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Lung; Microbial Sensitivity Tests; Rifampin; Rifamycins; Rifaximin; Tetracycline | 2015 |
Small angle X-ray scattering as a high-throughput method to classify antimicrobial modes of action.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactams; Chloramphenicol; Ciprofloxacin; Drug Discovery; Escherichia coli K12; High-Throughput Screening Assays; Microscopy, Electron, Transmission; Polymyxin B; Principal Component Analysis; Rifampin; Scattering, Small Angle; Tetracycline; X-Ray Diffraction | 2016 |
Retinal artery occlusion due to Bartonella henselae infection: a case series.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Bacterial; Bartonella henselae; Cat-Scratch Disease; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluorescein Angiography; Humans; Immunoglobulin M; Male; Middle Aged; Retinal Artery Occlusion; Retrospective Studies; Rifampin | 2016 |
Sugar-Grafted Cyclodextrin Nanocarrier as a "Trojan Horse" for Potentiating Antibiotic Activity.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Cyclodextrins; Ciprofloxacin; Click Chemistry; Drug Carriers; Drug Resistance, Bacterial; Erythromycin; Glucose; Humans; Mannose; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus | 2016 |
Validation of a treatment algorithm for orthopaedic implant-related infections with device-retention-results from a prospective observational cohort study.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Debridement; Female; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Orthopedic Procedures; Prospective Studies; Prosthesis Retention; Prosthesis-Related Infections; Rifampin; Switzerland; Treatment Outcome | 2016 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action.
Topics: Antitubercular Agents; Ciprofloxacin; Flow Cytometry; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin | 2016 |
Molecular Characterization of Methicillin-Resistant Staphylococcus aureus Bloodstream Isolates in a Turkish University Hospital Between 2002 and 2012.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Chromosomes, Bacterial; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Loci; Gentamicins; Hospitals, University; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Retrospective Studies; Rifampin; Staphylococcal Infections; Tetracycline; Turkey | 2016 |
Notes from the Field: Expanded Chemoprophylaxis Offered in Response to a Case of Meningococcal Meningitis in an Elementary School - Indiana, 2015.
Topics: Adult; Child; Ciprofloxacin; Contact Tracing; Female; Humans; Indiana; Male; Meningitis, Meningococcal; Neisseria meningitidis, Serogroup B; Practice Guidelines as Topic; Pregnancy; Rifampin; Schools | 2016 |
Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.
Topics: Adult; Anti-Bacterial Agents; Biofilms; Biological Assay; Chromatography, Liquid; Ciprofloxacin; Dried Blood Spot Testing; Drug Monitoring; Female; Fusidic Acid; Hematocrit; Humans; Male; Middle Aged; Prostheses and Implants; Prosthesis-Related Infections; Reproducibility of Results; Rifampin; Tandem Mass Spectrometry | 2016 |
Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
Topics: Animals; Antitubercular Agents; Bacterial Load; Bacterial Proteins; Biological Transport; Ciprofloxacin; Disease Models, Animal; Doxycycline; Female; Gene Expression; Gene Knockdown Techniques; Humans; Isoniazid; Lung; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Mycolic Acids; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2016 |
Porphyromonas pogonae identification from a soft tissue infection: The first human case.
Topics: Adult; Anti-Bacterial Agents; Bacteroidaceae Infections; Ciprofloxacin; DNA, Bacterial; Fractures, Bone; Humans; Male; Minocycline; Porphyromonas; Rifampin; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Soft Tissue Infections; Suppuration; Tigecycline | 2016 |
Inhibitory Interaction Potential of 22 Antituberculosis Drugs on Organic Anion and Cation Transporters of the SLC22A Family.
Topics: 1-Methyl-4-phenylpyridinium; Aminosalicylic Acid; Animals; Antitubercular Agents; Ciprofloxacin; HEK293 Cells; Humans; Inhibitory Concentration 50; Ion Transport; Kinetics; Levofloxacin; Linezolid; Metformin; Octamer Transcription Factor-1; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Organic Cation Transport Proteins; Organic Cation Transporter 2; Pyrazinamide; Rifabutin; Rifampin; Zidovudine | 2016 |
The role of apolipoprotein N-acyl transferase, Lnt, in the lipidation of factor H binding protein of Neisseria meningitidis strain MC58 and its potential as a drug target.
Topics: Acyltransferases; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Ciprofloxacin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Microbial Sensitivity Tests; Mutation; Neisseria meningitidis; Rifampin; Structure-Activity Relationship | 2017 |
Cutaneous Mycobacterium gordonae infection in an elderly diabetic returned traveller.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Diagnosis, Differential; Ethambutol; Humans; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Skin Diseases, Infectious; Travel | 2017 |
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software.
Topics: Ciprofloxacin; Clarithromycin; Computer Simulation; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Fluconazole; Humans; Itraconazole; Ketoconazole; Models, Biological; Paroxetine; Quinidine; Rifampin; Software | 2018 |
Biophysical control of the growth of Agrobacterium tumefaciens using extremely low frequency electromagnetic waves at resonance frequency.
Topics: Agrobacterium tumefaciens; Amikacin; Anti-Bacterial Agents; Carbenicillin; Cefaclor; Chloramphenicol; Ciprofloxacin; DNA, Bacterial; Electromagnetic Radiation; Fluoroquinolones; Gatifloxacin; Gentamicins; Plant Tumors; Rifampin; Solanum lycopersicum | 2017 |
Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Machine Learning; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Prevalence and serogroup changes of Neisseria meningitidis in South Korea, 2010-2016.
Topics: Adolescent; Adult; Aged; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Infant; Male; Meningitis, Meningococcal; Meningococcal Infections; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Multilocus Sequence Typing; Neisseria meningitidis; Neisseria meningitidis, Serogroup B; Neisseriaceae Infections; Prevalence; Republic of Korea; Rifampin; RNA, Ribosomal, 16S; Serogroup | 2018 |
Ciprofloxacin and Rifampin Dual Antibiotic-Loaded Biopolymer Chitosan Sponge for Bacterial Inhibition.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Bacterial Infections; Biopolymers; Chitosan; Chromatography, High Pressure Liquid; Ciprofloxacin; Mice; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus | 2018 |
Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016.
Topics: Adolescent; Ampicillin; Anti-Infective Agents; Brazil; Ceftriaxone; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Humans; Infant; Male; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin G; Rifampin | 2018 |
Ciprofloxacin and acute aortic valve damage.
Topics: Aged; Aortic Valve; Arthroplasty, Replacement, Knee; Ciprofloxacin; Cloxacillin; Collagen; Fluoroquinolones; Heart Valve Diseases; Humans; Male; Prosthesis-Related Infections; Rifampin; Tendinopathy | 2018 |
Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays.
Topics: Aminoglycosides; Anti-Bacterial Agents; Calcium; Ciprofloxacin; Colistin; Culture Media; Depsipeptides; Escherichia coli; Factor Analysis, Statistical; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Plastics; Polymyxin B; Polysorbates; Rifampin; Teicoplanin; Trimethoprim; Vancomycin | 2019 |
Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Empirical Research; Enterobacteriaceae; Female; Gene Expression; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Retrospective Studies; Rifampin; Spine; Streptococcus; Vancomycin | 2019 |
Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria.
Topics: Adenosine; Animals; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Prosthesis-Related Infections; Pseudomonas aeruginosa; Purinergic P2Y Receptor Antagonists; Rifampin; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Ticagrelor; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
MDR/XDR-TB Colour Test for drug susceptibility testing of Mycobacterium tuberculosis, Northwest Ethiopia.
Topics: Adolescent; Adult; Antitubercular Agents; Ciprofloxacin; Culture Media; Ethiopia; Extensively Drug-Resistant Tuberculosis; Female; Health Resources; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Development and validation of a UPLC-MS/MS method for simultaneous quantification of levofloxacin, ciprofloxacin, moxifloxacin and rifampicin in human plasma: Application to the therapeutic drug monitoring in osteoarticular infections.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Monitoring; Female; Humans; Levofloxacin; Limit of Detection; Male; Middle Aged; Moxifloxacin; Plasma; Reproducibility of Results; Rifampin; Tandem Mass Spectrometry | 2020 |
Incidence, Clinical Manifestation, Treatment Outcome, and Drug Susceptibility Pattern of Nontuberculous Mycobacteria in HIV Patients in Tehran, Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Ciprofloxacin; Female; HIV Infections; Humans; Incidence; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Young Adult | 2020 |
Effect of different drugs and drug combinations on killing stationary phase and biofilms recovered cells of Bartonella henselae in vitro.
Topics: Analgesics; Azithromycin; Bartonella henselae; Biofilms; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Gentamicins; Methylene Blue; Microbial Sensitivity Tests; Microbial Viability; Nitrofurantoin; Rifampin | 2020 |
Early neonatal sepsis and meningitis caused by Elizabethkingia meningoseptica in Saudi Arabia.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Infant, Newborn; Meningitis, Bacterial; Rifampin; Saudi Arabia; Sepsis; Treatment Outcome; Vancomycin | 2020 |
Australian Meningococcal Surveillance Programme annual report, 2019.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Australia; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Female; History, 21st Century; Humans; Infant; Male; Meningococcal Infections; Microbial Sensitivity Tests; Middle Aged; Neisseria meningitidis; Penicillins; Public Health Surveillance; Rifampin; Serogroup; Serotyping; Young Adult | 2020 |
Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Biological Products; Calorimetry; Chloramphenicol; Ciprofloxacin; Metabolomics; Microbial Sensitivity Tests; Rifampin; Tetracycline | 2020 |
Antibiotic susceptibility and molecular analysis of invasive Neisseria meningitidis recovered in the Republic of Ireland, 1996 to 2016.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Genotype; Humans; Ireland; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillins; Rifampin | 2021 |
Ciprofloxacin population pharmacokinetics during long-term treatment of osteoarticular infections.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Humans; Retrospective Studies; Rifampin; Staphylococcal Infections | 2021 |
Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19).
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; England; Humans; Meningitis, Meningococcal; Neisseria meningitidis; Northern Ireland; Penicillins; Rifampin; Wales | 2021 |
Rifampicin-induced fever during treatment against staphylococcal biofilm in a patient with periprosthetic joint infection.
Topics: Aged; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Humans; Male; Prosthesis-Related Infections; Retrospective Studies; Rifampin | 2022 |
The Bacteriology of Skin Lesions in Patients with Hidradenitis Suppurativa Is Associated with Previous Antibiotic Treatment in the Community Setting: A Referral Center Experience.
Topics: Adult; Anti-Bacterial Agents; Bacteriology; Ciprofloxacin; Clindamycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Hidradenitis Suppurativa; Humans; Referral and Consultation; Rifampin; Sulfamethoxazole; Trimethoprim | 2022 |
The Error-Prone Polymerase DnaE2 Mediates the Evolution of Antibiotic Resistance in Persister Mycobacterial Cells.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Mycobacterium tuberculosis; Rifampin | 2022 |
Involvement of the SCO3366 efflux pump from S. coelicolor in rifampicin resistance and its regulation by a TetR regulator.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Membrane Transport Proteins; Rifampin; Streptomyces coelicolor | 2022 |
Congenital brucellosis associated with subsequent Klebsiella pneumoniae co-infection in a premature neonate: A rare case report.
Topics: Amikacin; Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Coinfection; Female; Gentamicins; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Respiratory Distress Syndrome; Rifampin; Sepsis | 2022 |
Impact of narrowing perioperative antibiotic prophylaxis for left ventricular assist device implantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ciprofloxacin; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Retrospective Studies; Rifampin; Treatment Outcome; Vancomycin | 2022 |
Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Chloramphenicol; Ciprofloxacin; Croatia; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Prevalence; Rifampin; Streptomycin; Tetracycline; Vancomycin | 2022 |
Understanding the suitability of established antibiotics for oral inhalation from a pharmacokinetic perspective: an integrated model-based investigation based on rifampicin, ciprofloxacin and tigecycline in vivo data.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Ciprofloxacin; Humans; Models, Biological; Rats; Rifampin; Tigecycline | 2022 |
Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Ifosfamide; Imipenem; Linezolid; Microbial Sensitivity Tests; Mycetoma; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Detection of Genes Encoding Microbial Surface Component Recognizing Adhesive Matrix Molecules in Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefoxitin; Ceftaroline; Chloramphenicol; Ciprofloxacin; Clindamycin; Erythromycin; Gentamicins; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pyoderma; Rifampin; Staphylococcus aureus | 2023 |
Synthesis of Glycopolymer Micelles for Antibiotic Delivery.
Topics: Anti-Bacterial Agents; Carbohydrates; Ciprofloxacin; Drug Carriers; Micelles; Polyesters; Polyethylene Glycols; Rifampin | 2023 |
The canonical Brucella species-host dependency is changing, however, the antibiotic susceptibility profiles remain unchanged.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Cattle; Cefoperazone; Ciprofloxacin; Doxycycline; Gentamicins; Humans; Mammals; Microbial Sensitivity Tests; Rifampin; Sheep; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Synergistic effect of two antimicrobial peptides, BP203 and MAP-0403 J-2 with conventional antibiotics against colistin-resistant Escherichia coli and Klebsiella pneumoniae clinical isolates.
Topics: Anti-Bacterial Agents; Antimicrobial Peptides; Ceftazidime; Chloramphenicol; Ciprofloxacin; Colistin; Drug Synergism; Escherichia coli; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Rifampin | 2023 |
Insight into the on/off switch that regulates expression of the MSMEG-3762/63 efflux pump in Mycobacterium smegmatis.
Topics: Bacterial Proteins; Ciprofloxacin; Humans; Mycobacterium smegmatis; Mycobacterium tuberculosis; Rifampin; Tuberculosis | 2023 |